key: cord-0076069-ipbrg5di
authors: nan
title: 41st International Symposium on Intensive Care and Emergency Medicine
date: 2022-03-25
journal: Crit Care
DOI: 10.1186/s13054-022-03927-z
sha: 649cc30e0fd1e64769e4ffc91de178ea3b367bb3
doc_id: 76069
cord_uid: ipbrg5di

nan

The detection of potential organ donors is a fundamental step to meet patients' wishes in end-of-life-care as well as the demand for transplantable organs. Organ donation (OD) after neurologic determination of death is the only accepted legal option in Highest temperature (C) 37.0 36.5 36.9 < 0.001 Introduction: Although COVID-19 affects primarily the respiratory system, several studies have shown evidence of cardiovascular alterations and right ventricular dysfunction. Our aim was to evaluated cardiac function and its association with lung function, hemodynamic compromise and mortality. Methods: Prospective, cross-sectional multicenter study in four university-affiliated hospitals in Chile. All consecutive patients with COVID-19 ARDS on mechanical ventilation admitted between April and July 2020 were included. Transthoracic echocardiography was performed within the first 24 h of intubation. Results: Consecutive 140 patients on mechanical ventilation with COVID-19 ARDS were included in the study, the mean age was 57 ± 11 years, PaO2/FiO2 ratio was 155 [IQR 107-177], cardiac output was 5.1 L/min [IQR 4.5-6.2] and 86% of the patients required norepinephrine. ICU mortality was 29% (40 patients). Fifty-four patients (39%) exhibited right ventricle dilation and 20 of them (37%) exhibited acute cor pulmonale (ACP). Eight of twenty (40%) patients with ACP exhibited pulmonary embolism. Patients with ACP had higher norepinephrine requirement, lower stroke volume, tachycardia, prolonged capillary refill time and higher lactate levels. In addition, acute cor pulmonale patients presented lower compliance, higher driving pressure and the presence of respiratory acidosis. Left ventricular systolic function was normal or hyperkinetic in most cases and only thirteen patients (9%) exhibited left ventricular systolic dysfunction (ejection fraction < 45%).

In the multivariate analysis acute core pulmonale, PaO2/FiO2 ratio and pH were independent predictors of mortality (Table 1) . Conclusions: Right ventricular dilation is highly prevalent in mechanically ventilated patients with COVID-19 ARDS. The presence of acute cor pulmonale is associated with poorer lung function, but only in 40% of patients it was associated to pulmonary embolism. Acute cor pulmonale is an independent risk factor for mortality in the ICU. Introduction: Right ventricular (RV)-pulmonary circuit interaction is important to consider in sepsis given the propensity for right ventricular dysfunction (RVD) and pulmonary hypertension (PH). RVD is associated with increased mortality. In PH a pulmonary valve acceleration time (PAT) of < 90 ms and PAT/pulmonary artery systolic pressure (PASP) ratio of < 2 show strong correlation with pulmonary vascular resistance (PVR) of > 3 wood units (WU). Mid-systolic notching predicts worse outcomes in this group. The therapeutic and prognostic significance of altered RVOT flow profiles in sepsis is unknown. Targeted individualised treatment strategies aimed at minimising insult to the pulmonary vasculature and pressure sensitive RV may be of benefit [1] . Analysis of the RVOT flow profile may alert the intensivist to early RVD in sepsis [2] . Methods: Single centre, retrospective analysis of a 110 patients with sepsis who had a transthroacic echo (TTE) with RVOT pulsed wave 

Introduction: Point-of-care ultrasound (POCUS) is a useful diagnostic tool in noninvasive assessment of critically ill patients. Mortality of especially elderly patients with COVID-19 pneumonia is high and there is still scarcity of definitive predictors. Aim of our study was to assess the prediction value of combined lung and heart POCUS data on mortality of elderly critically ill patients with severe COVID-19 pneumonia. Methods: Data of patients older than 70 years, with severe COVID-19 pneumonia admitted to 22-bed mixed ICU, level 3, was analysed retrospectively. POCUS was performed on all admitted patients; our parameters of interest were pulmonary artery systolic pressure (PAPs) and diffuse B-line lung pattern (B-pattern).

Results: A total of 116 patients (average age 77 ± 5 years) were included. Average length of ICU stay was 10.7 ± 8.9 days. High-flow oxygenation, non-invasive ventilation and invasive mechanical ventilation were at some point used to support 36/116, 39/116 and 75/116 patients respectively. ICU mortality was 59/116 (50.9%). ICU stay was shorter in survivors (8.8 ± 8.3 vs 12.6 ± 9.3 days, p = 0.02). PAPs was lower in ICU survivors (32.5 ± 9.8 vs. 40.4 ± 14.3 mmHg, p = 0.024) ( Table 1) . B-pattern was more often detected in non-survivals (35/24 (59%) vs. 19/38 (33%), p = 0.005). PAPs and B-pattern were both univariate predictors of mortality. PAPs was an independent predictor of ICU mortality (OR 1.0683, 95%CI: 1.0108-1.1291, p = 0.02).

Conclusions: PAPs at admission is an independent predictor of ICU mortality of elderly patients with severe COVID-19 pneumonia.

Moderate elevations in positive end expiratory pressure (PEEP) in a patient with ARDS and severe systolic heart failure can decrease oxygen delivery: a case report C David 1 , C Pierrakos 2 , R Attou 2 , K Kaefer 2 , D Velissaris 3 , PM Honore 2 , D De Bels 2 1 Institut Jules Bordet, Intensive Care, Brussels, Belgium, 2 CHU Brugmann, Intensive Care, Brussels, Belgium, 3 University Hospital of Patras, Intensive Care, Pio, Greece Critical Care 2022, 26(Suppl 1): P023

Introduction: Positive end-expiratory pressure (PEEP) may improve oxygenation and left ventricular (LV) function in patients with acute respiratory distress (ARDS). The aim of this case study was to assess the hemodynamic and oxygenation effects of moderate PEEP elevation in an invasively ventilated patient with ARDS and severe systolic LV dysfunction. We hypothesized that moderate PEEP elevations may improve oxygenation, LV function and oxygen delivery (DO 2 ). Methods: A 72-year-old patient with severe heart failure and severe ARDS (PaO 2 /FiO 2 : 60) due to Legionella infection was assessed. The patient was submitted to invasive ventilation (tidal volume of 5.6 ml/kg of predicted body weight and PEEP of 3 cm H 2 O). PEEP was progressively increased up to 15 cm H 2 O for improving oxygenation. Echocardiographic and hemodynamic variables from Swan-Ganz catheter were obtained before and 20 min after each PEEP modification.

Results: At baseline, the patient had a LV ejection fraction of 10%, tricuspid annular plane systolic excursion (TAPSE) of 19 mm and cardiac index of 2.5 l/min/m 2 . PEEP elevation increased oxygen saturation (from 91 to 95%), mixed venous saturation (60% to 72%) and driving pressure (11 to 15 cmH 2 O) but DO 2 decreased (329 to 311 ml/min/m 2 ) (Fig. 1 ). LV function improved as indicated by left ventricular global longitudinal strain (− 9% to − 14%) and LV myocardial performance index (LV-MPI 0.55 to 0.38). In contrast, right ventricular (RV) function deteriorated as indicated by RV myocardial performance (RV-MPI 0.31 to 0.58). TAPSE/systolic pulmonary artery pressure ratio decreased from 0.32 to 0.11. Conclusions: This case suggests that in a patient with severe systolic heart dysfunction and ARDS, moderate PEEP elevations may deteriorate oxygen delivery despite left ventricular function and oxygenation improvement. RV-pulmonary vascular coupling assessment can be clinical relevant parameter for PEEP choice. Consent to Publish: Written informed consent was obtained from the next of kin. Introduction: Portal vein Doppler pulsatility measured by transesophageal echocardiography is a promising imaging ultrasound biomarker of the hemodynamic impact of right ventricular failure in cardiac surgery. The objective of the study was to determine whether the presence of abnormal portal vein flow pulsatility is associated with a longer duration of invasive life support and adverse post-operative outcomes after cardiac surgery in high-risk patients. Methods: Multicenter cohort study using pulsed-wave Doppler assessments of the portal vein flow before initiation of cardiopulmonary bypass (CPB) (T1) and after CPB separation (T2). Abnormal pulsatility was defined as a portal pulsatility fraction (PPF) of ≥ 50% (PPF50). The primary outcome studied was the cumulative time in perioperative organ dysfunction (T POD ) requiring invasive life support during the first 28 days after surgery. Secondary outcomes included major post-operative complications. at T1 showed significant association with T POD . The detection of PPF50 at T2 was associated with a higher rate of major post-operative complications (36.4% versus 20.3%, p = 0.006). Moreover, de novo PPF50 at T2 was associated with the highest rate of major postoperative complications (40.5%).

The presence of PPF50 in cardiac surgery is associated to have a longer duration of life support therapy and complications after cardiac surgery in high-risk patients. Consent to Publish: Study protocol was approved by the research and ethics committee of each participating institution. Written informed consent was obtained from all subjects. Funding: CARF.

Introduction: Intraoperative hypotension is associated with postoperative myocardial injury, acute kidney injury, and death and thus should be avoided. In clinical practice, specific causes of intraoperative hypotension are often neglected. A detailed understanding of underlying hemodynamic alterations would allow treating intraoperative hypotension causally. We sought to use artificial intelligence to identify intraoperative hypotension phenotypes characterized by different underlying hemodynamic alterations in major abdominal surgery patients. We hypothesized that artificial intelligence can identify intraoperative hypotension phenotypes. Methods: We conducted a secondary analysis of intraoperative hemodynamic measurements from a prospective observational study in 100 patients who had major abdominal surgery with general anesthesia including stroke volume index, heart rate, cardiac index, systemic vascular resistance index, and pulse pressure variation measurements. We defined intraoperative hypotension as mean arterial pressure (MAP) ≤ 65 mmHg or MAP between 66 and 75 mmHg when the norepinephrine infusion rate exceeded 0.1 µg/kg/min. To identify intraoperative hypotension phenotypes we used an artificial intelligence algorithm-specifically, hierarchical clustering and then applied the algorithm to pairwise Euclidean distances using Ward's minimum variance method. Results: There were 615 episodes of intraoperative hypotension in 82 patients. Artificial intelligence revealed six as the optimal number of intraoperative hypotension phenotypes. Based on their clinical characteristics, we labeled the phenotypes as (1) myocardial depression, (2) bradycardia, (3) vasodilation with CI increase, (4) vasodilation without CI increase, (5) hypovolemia, and (6) mixed type (Fig. 1) . Conclusions: Artificial intelligence identified six intraoperative hypotension phenotypes. Considering these phenotypes may allow treating intraoperative hypotension causally with specific therapeutic interventions.

Introduction: Cuff devices offer ample possibilities to modulate blood flow and pulse propagation. Vasculature response to occlusion perturbations may enable measurement of arterial compliance, peripheral resistance, and beat-to-beat BP calibration [1] . However, in standard practice the cuff is still only used for intermittent, largely inaccurate BP measurements. Strong assumptions are required to explain vascular occlusion mechanisms. Additional research modalities are needed for further development of cuff measurements. Methods: In this study, we employed MRI to provide new insights over the influence of the cuff on arterial pulsations. We performed MRI scans on 10 healthy participants to observe vasculature, tissue, cuff interaction. Written informed consent was obtained from the participants. Results: The images provide insights into several assumptions. Unpredictable cuff folding occurs during inflation; compression of the arm is not isotropic (Fig. 1 ). This effect possibly hinders accurate modulation of arterial transmural pressure. The artery location is subject dependent; oscillations of superficial arteries are likely expressed differently than oscillations of arteries located within subcutaneous fat. Complex tissue compression/displacement occurs under the cuff; arterial volume pulsations might not be equivalent to arm volume pulsations. Artery size is quantified revealing nonlinear collapse characteristics and non-uniform collapse across the length of the cuff. No significant changes in arterial properties were detected during two consecutive inflations. Conclusions: These results are useful for improving existing BP measurements and enabling measurement of arterial compliance, peripheral resistance and beat-to-beat BP. The cuff interaction with the vasculature is oversimplified by existing models. MRI is an essential research tool for further development of cuff-based physiological measurements.

Introduction: In septic shock, the surviving sepsis Campaign (SSC) guidelines give clear recommendations about the initial mean arterial pressure (MAP) goals but remain incomplete regarding further goals. The cerebral circulation is concerned by the blood flow redistribution during shock and can be assessed by transcranial Doppler (TCD). The purpose of this study was to assess the contribution of TCD in hemodynamic management during the early phase of septic shock by comparing a personalized TCD-guided hemodynamic goals to the SSC recommendations. Methods: Fifty patients meeting the Sepsis-3 consensus criteria were enrolled and equally randomized into 2 groups. Concerning norepinephrine infusion, we aimed in the standard group to maintain a MAP ≥ 65 mmHg with negative blood lactate level during 72 h after shock onset. For the TCD-guided group, MAP goals and Norepinephrine infusion rate were determined according to TCD measurements to achieve a pulsatility index (PI) < 1.3. Sepsis associated encephalopathy (SAE) was diagnosed using CAM-ICU score > 3 or a GCS deterioration. The main outcome was 28 days mortality. Results: The 2 groups were comparable regarding demographic and initial severity scores. We noticed an increased mortality (p = 0.031), higher incidence of SAE (p < 10 −3 ) and cerebral hypoperfusion (p < 10 −3 ) in the standard group. In TCD-group, TCD measurements were improved with lower PI (p < 10 −4 ). MAP was higher in the TCDgroup (p < 10 −4 ) along the study period with no difference in norepinephrine mean infusion rate (p = 0.497). No difference in final SOFA scores, duration of mechanical ventilation, ICU length of stay and duration of Norepinephrine infusion were recorded. Conclusions: Monitoring of the cerebral perfusion using TCD is useful in personalizing hemodynamic goals during septic shock and thus improves mortality and neurological outcome. Introduction: Responsiveness to norepinephrine dose variation in terms of mean arterial pressure (MAP) change is highly variable in acute circulatory failure. This preliminary study aimed to investigate the influencing factors of the pharmacodynamic effect of norepinephrine on MAP in critically ill patients. Methods: Monocentric, observational, prospective study conducted at the intensive care unit of Bicêtre Hospital, Paris. Patients with diagnosis of circulatory failure requiring norepinephrine and invasive pressure monitoring were included. To characterize MAP responsiveness, the maximal amplitude of MAP change over the amplitude of norepinephrine dose change (Emax/∆NE) was defined. Results: From January to July 2021, 29 patients presenting 86 episodes of norepinephrine dose change, 55 increases and 31 decreases, were included. The main origin of shock was sepsis in 59 episodes, followed by hypovolemic/hemorrhagic shock in 16 episodes and nonseptic vasoplegia in 11 episodes. Septic shock was characterized by lower baseline values of mean (66, 58-86 vs 82, 71-103 mmHg, respectively) and diastolic arterial pressure (50, 44-64 vs 64, 55-78 mmHg, respectively) and a larger amplitude of norepinephrine dose change (0.08, 0.05-0.12 vs 0.04, 0.03-0.06 µg/kg/min, respectively). Emax/∆NE was significantly lower in septic shock (315, 161-590 vs 575, 401-776 vs 446, 336-1119 mmHg/µg/kg/min, respectively, p = 0.03, Fig. 1 ). At multiple logistic regression analysis, preexisting hypertension, body temperature at the episode time and shock etiology were associated with Emax/∆NE (p = 0.002), and body temperature and C-reactive protein influenced Emax/∆NE in septic shock episodes (p = 0.003).

Conclusions: Septic shock seems to be characterized by lower vascular reactivity compared to other shock etiologies and pressure responsiveness is not identical to other distributive shocks. Introduction: In refractory cardiogenic shock, VA-ECMO may be employed to maintain end organ perfusion. Measures to hasten weaning from VA-ECMO support are sought to minimize complications. Levosimendan is an inodilator which is shown to facilitate weaning of VA-ECMO in post cardiac surgery patients. Its benefit on patients without cardiac surgery is uncertain. We aim to study the effect of levosimendan on survival of ICU patients receiving VA-ECMO support.

Methods: This is a retrospective cohort study carried out in the 24-bed mixed medical/surgical ICU of a regional hospital in Hong Kong from January 1, 2015, to July 31, 2021. Patients admitted for refractory cardiogenic shock or post cardiac arrest requiring peripheral VA-ECMO support were recruited. Results: A total of 51 patients receiving peripheral VA-ECMO support were included. Among them, 19 patients received levosimendan (LEVO), while 32 did not (control). Demographics including age, sex, medical co-morbidities, and the APACHE IV score were not significantly different between groups. Acute myocardial infarction, as the indication for ECMO (84.2% vs 46.9%, p = 0.016), and the concomitant use of intra-aortic balloon pump (IABP) (78.9% vs 37.5%, p = 0.008) were more commonly found in the LEVO group than the control group. The primary endpoint was 30-day mortality, which was significantly lower in the LEVO group (36.8% vs 68.8%, p = 0.026). Kaplan-Meier plots showed improvement of 30-day (p = 0.022) and 90-day mortality (p = 0.039) for patients who received levosimendan. Statistically significant secondary outcomes included ICU mortality (31.6% vs 62.5%, p = 0.033) and ICU length of stay (6.1 vs 3.3 days, p = 0.032). Low total levosimendan dose, defined as less than 140mcg/kg, predicted ICU mortality (AUROC 0.885, 95% CI 0.691-1.000, p = 0.009). Conclusions: Levosimendan use was associated with improved 30-day mortality in patients suffering from refractory cardiogenic shock or post cardiac arrest treated with peripheral VA-ECMO.

Introduction: Cardiac function is known to be negatively impacted by sepsis. Monitoring Cardiac Output (CO) trends over the course of treatment may provide insight into cardiac function and may be used to predict patient outcome. The goal of this study was to explore the relationship between the change in stroke volume and outcome in critically ill patients. Methods: The Starling Registry study is an observational registry study evaluating trends in CO and SV (Stroke Volume) over time as related to patient outcome (NCT04648293). Patients that exhibited an overall improvement in CO (first CO measurement compared to last CO measurement) were compared to those who did not exhibit improvement. Introduction: Handheld vital microscopy allows direct observation of red blood cells within the sublingual microcirculation. Automated analysis allows quantifying microcirculatory tissue perfusion variables-including tissue red blood cell perfusion (tRBCp). We aimed to (1) describe baseline microcirculatory tissue perfusion in patients presenting for elective non-cardiac surgery and (2) test that microcirculatory tissue perfusion is preserved during general anaesthesia and non-cardiac surgery. Methods: In this prospective observational study, we measured sublingual microcirculation using incident dark field imaging with automated analysis at baseline before induction of general anaesthesia, under general anaesthesia before surgical incision, and every 30 min during surgery in 120 elective non-cardiac surgery patients (major abdominal, orthopaedic or trauma, and minor urologic surgery). We also performed measurements in young healthy volunteers. Results: We automatically analysed 3687 microcirculation video sequences. Microcirculatory tissue perfusion variables varied substantially between individuals-but ranges were similar between patients and volunteers. Under general anaesthesia before surgical incision, there were no important changes in tRBCp, functional capillary density, and capillary haematocrit compared to pre-induction baseline. However, total vessel density was higher and red blood cell velocity and the proportion of perfused vessels were lower under general 

We aimed to determine the incidence of mechanical complications and to identify associated independent risk factors in a healthcare system where real-time ultrasound guidance is clinical practice for central venous access. Methods: All central venous catheter insertions in patients ≥ 16 years at four emergency care hospitals between 2 March 2019 and 31 Dec 2020 were eligible for inclusion. During the study period, dedicated collaborators at each study site continuously reviewed the insertion records and chest X-rays. The primary outcome measures were mechanical complications that occurred within 24 h after catheterisation. Multivariable logistic regression analysis was used to determine associations between independent variables and major mechanical complications defined as pneumothorax, arterial catheterisation, major bleeding, serious cardiac arrhythmia and persisting nerve injury. The study was registered at clinicaltrials.gov (NCT03782324) and the study protocol was published in September 2019 [1] . Results: In total, 12 667 central venous catheter insertions were prospectively included. (Table 1) . Conclusions: In a healthcare system where real-time ultrasound guidance is clinical practice for central venous access, the incidence of major mechanical complications was found to be low. Patient BMI < 20 kg/m 2 , male operator sex, limited operator experience, and more than one skin puncture were identified as independent risk factors of major mechanical complications. 

We assessed the role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients hospitalized for infective endocarditis (IE) for emergent valve surgery due to acute heart failure (AHF).

The study enrolled 100 patients, who underwent valve surgery for IE between 2019 and 2021. All patients were divided into groups according to the degree of preoperative heart failure by NYHA classification. For each group the limit values of NT-proBNP were determined. The predictors of AHF were analyzed, and clinical results of patients with non-AHF (n = 44) were evaluated and compared. Introduction: There are still lack of usefulness biomarkers of heart failure in pediatric cardiology practice. Soluble ST2 is one of the most promising laboratory marker of heart failure. It's already widely used for diagnostic and prognostic goals in adults [1] , but it's not much investigated in children [2] . We suppose serum soluble ST2 is able to become a new cardiac biomarker of cardiac muscle injury, remodeling and fibrosis, and heart failure outcomes stratification in pediatric population. is an easily derived parameter identifying insufficient tissue perfusion. The purpose of this study was to evaluate the clinical relevance of high values of P va CO 2 in COVID − 19 patients early after their admission to intensive care unit (ICU). We speculated that high P va CO 2 values might be associated with poor outcome in critically ill COVID-19 patients. Methods: This was a retrospective study conducted in two independent centers of Belgium. We included patients treated in the first wave of the national outbreak with available P va CO 2 within 3 days of admission and without severe hypercapnia (PCO 2 > 75 mmHg). The highest value was registered. Normal values were considered ≤ 6 mmHg, moderate elevations 7 − 9 mmHg, and high elevations > 9 mmHg. The primary outcome was ICU discharge alive and secondary outcome mortality at 28 days. Results: Seventy-three patients were included with median age of 60 years (IQR: 52 to 68), and simplified acute physiology score II (SAPS II) 26.1 (IQR: 19.8 to 29.5). Fifty-three (76%) patients needed invasive ventilation within 24 h after ICU admission (12 h (IQR: 12 to 24). The worst ratio of partial pressure arterial oxygen to the fraction of inspired oxygen (PaO 2 /FiO 2 ) within 3 days after admission was 151 (IQR: 86 to 243) and P va CO 2 6 mmHg (IQR: 5 to 9). P va CO 2 > 9 mmHg was associated with longer ICU stay (ICU free days: 0 days (0 − 0) vs 1 day (0 − 18), p = 0.02), independently of PaO 2 /FiO 2 and SAPS II score (HR: 0.21, Introduction: Calculation of perfusion and oxygenation indicators often includes the simultaneous measurement of arterial and venous gases in critically ill patients. This entails a large amount of supplies and inconvenience caused to patients who require frequent arterial blood sampling, a situation that is aggravated if there is no arterial line, as is the case in developing countries. The objective of this study was to determine the degree of correlation and concordance of the gasimetric values of arteriovenous oxygen difference, oxygen extraction and intrapulmonary shunt calculated with venous gases and pulse oximetry compared with the calculations performed in arteriovenous gases. Methods: One hundred hospitalized patients from intensive care units in Colombia were evaluated. Adult patients with medical or surgical pathologies were included. All patients underwent arterial and venous gasimetry upon admission and 6 h later, and arterial and venous gas measurements were performed in all of them, together with the recording of pulse oximetry at the time of sample collection.

Results: Average age of 63.3 years, 65% was men, an average APACHE of 10.75 (95% CI: 9.3-12.1) and a SOFA of 5.2 ( 95% CI: 4.5-6.06). An excellent correlation was found between the values of arteriovenous oxygen difference and oxygen extraction measured with venous gases and pulse oximetry compared with arteriovenous gases (p < 0.00001). An excellent agreement was also found for the values in the case of the arteriovenous oxygen difference; and for oxygen extraction. In the case of the intrapulmonary shunt, a good correlation was also found between the two measurements with a good agreement (p < 0.00001). Conclusions: The calculation of the values of arteriovenous oxygen difference, oxygen extraction and intrapulmonary shunt can be performed from the venous blood gas only and the pulse oximetry taken at the same time without the need to take an arterial sample. This can reduce costs and inconvenience for critically ill patients. Introduction: The hydrogen ion delta was described for quantifying the degree of acidosis or alkalosis originated in determinants other than CO 2 , that is, the metabolic component of the acid-base state. The indicator has not been compared with the excess base, for which the present study was developed. The objective of this study is determine the degree of correlation between the base excess and the delta of hydrogen ions and the concordance for the diagnosis of acid-base disorders of metabolic origin. Methods: One hundred hospitalized patients from intensive care units of Colombian, adult patients with medical or surgical pathologies were included. All patients underwent arterial and venous blood gas analysis upon admission and 6 h later, and measurements of base excess and delta of hydrogen ions were performed at the same time. The group of patients was evaluated during their stay in the intensive care unit. Correlation of the base excess and the delta of hydrogen ions using Pearson's coefficient and Kappa coefficient. Results: Average age of 63.3 years, 65% was men average APACHE of 10.75 (95% CI: 9.3-12.1) and a SOFA of 5.2 (95% CI: 4.5-6.06). A significant correlation was found between the base excess and the delta of hydrogen ions. For the diagnosis of metabolic acidosis, the excess base and the hydrogen ion delta, an excellent agreement was found with a Kappa of 0.91 (p < 0.0001). The change in the delta of hydrogens and the change in the excess base between the first and second samples showed a significant area under the ROC curve for the prediction of mortality. (for the delta of hydrogens AUC: 0.779; for the base excess AUC: 0.70). Conclusions: There is a good correlation between the values of base excess and delta of hydrogen ions, and the concordance for the diagnosis of acid-base imbalances is excellent. The change in delta H and excess base in the first 6 h is a predictor of mortality. The hydrogen ion delta is a useful tool in describing the acid-base status of critically ill patients. Critical Care (2022) 26:72 handlings. A number of studies suggest that simultaneously with lactate, pyruvate should also be measured, since this might augment prognostic ability, and provide a better understanding of the underlying metabolic alterations in ICU patients. Hence, the aim of the present study was to elucidate the relationship between lactate levels, the lactate-to-puruvate (LP) ratio, and clinical outcome in mechanically ventilated COVID-19 patients. Methods: Lactate and pyruvate were serially measured during the first 24 h of ICU stay. A group of ICU non-COVID-19 patients was additionally studied. The subgroup of COVID-19 patients presenting with elevated lactate was also analysed in an attempt to assess the contribution of hypoxic and non-hypoxic causes of hyperlactatemia. Results: The majority of COVID-19 patients (82.5%) had normal lactate and LP ratio on ICU admission. A small, yet significant percentage of patients, who had either elevated lactate levels or a high LP ratio, had a significantly higher risk of ICU mortality (72.7% vs. 34.6%, p = 0.04). Finally, high lactate seemed to be related to hypoxic or non-hypoxic causes in COVID-19 patients. Conclusions: In our critically ill COVID-19 patients, hyperlactatemia was not only due to tissue hypoperfusion. Furthermore, elevated lactate levels or high LP ratios on admission to the ICU could be associated with poor clinical outcome. Introduction: Obesity paradox is an established phenomenon regarding overweight patients treated in ICUs. Mortality of especially elderly patients with COVID-19 pneumonia is high and there is still scarcity of definitive predictors. Aim of our study was to assess the prediction value of Body Mass Index (BMI) on mortality of elderly critically ill with severe COVID-19 pneumonia. Methods: Data of patients, older than 70 years, with severe COVID-19 pneumonia, admitted to 22-bed mixed ICU, level 3, was analysed retrospectively. We especially focused on BMI and lactate levels at admission. Results: A total of 102 patients (average age 77 ± 5 years) were included. Average length of ICU stay was 11.4 ± 9.2 days. Average BMI was 29.3 ± 5.2 kg/m 2 and lactate levels 2.9 ± 3.2 mmol/l (Table 1) . High-flow oxygenation, non-invasive ventilation and invasive ventilation were at some point used to support 34/102, 36/102 and 69/102 patients respectively. ICU mortality was 51/102 (50.0%). ICU stay was shorter in survivors (9.1 ± 8.5 vs 13.6 ± 9.4 days, p = 0.01). BMI was higher in survivors (30.5 ± 5.6 vs. 28.1 ± 4.5 kg/m 2 , p = 0.02); 26/51 (51%) survivors and only 15/51 (29%) non-survivors had BMI ≥ 30 kg/ m 2 (chi-square p = 0.043). At admission BMI (OR 0.9153, 95%CI 0.8610-0.9730, p = 0.0045) and lactate levels (OR 1.3492, 95%CI 1.0856-1.676, p = 0.0069) were independent predictors of ICU mortality. Conclusions: BMI and lactate levels at admission are independent predictors of ICU mortality of elderly patients with severe COVID-19 pneumonia. The study confirmed the obesity paradox in elderly critically ill with severe COVID-19 pneumonia.

The effect of premorbid metformin use on lactate kinetics, kidney injury and mortality in patients with sepsis and septic shock: an observational study N Van Moorter 1 , T Tackaert 2 , N De Neve 3 , B Van Vlem 4 , K De Decker 3 Introduction: Sepsis and septic shock cause significant mortality worldwide, with no targeted molecular therapies available. Metformin has pleomorphic effects that may be beneficial in sepsis, but at present, the impact of metformin exposure in sepsis remains controversial. Metformin might alter lactate metabolism, but little is known about its impact on lactate kinetics. We therefore investigated the impact of preadmission metformin use on lactate kinetics, acute kidney injury (AKI) and mortality in sepsis and septic shock. Methods: We conducted a retrospective cohort study in patients with sepsis and septic shock admitted to the ICU between January 2013 and September 2020, including 77 users and 390 non-users (subdivided in diabetics, n = 48 and non-diabetics, n = 342). AKI staging was based on the AKIN criteria including urinary output data. Chronic haemodialysis patients were excluded. Results: Groups and subgroups did not differ in severity of illness nor sepsis aetiology. Admission lactate levels were not different, but evolution in lactate over the first 24 h showed a larger decrease in users vs nonusers (median − 53% vs − 36%, p = 0.010). No difference in AKI or need for renal replacement therapy was found. Mortality data showed lower mortality in users vs nonusers in case of septic shock (21.9% (n = 7) vs 42.7% (n = 61) for 90-d mortality, p = 0.029, OR 0.38 [95% CI: 0.15-0.93]) (see Table 1 ), but revealed no significant differences in the general sepsis population. Conclusions: In our data, preadmission metformin use is associated with a significantly larger decrease in lactate after admission in sepsis or septic shock and with reduced mortality in septic shock. This underscores the need for further studies investigating the interplay between metformin, lactate and sepsis, thereby exploring the potential of metformin use in the treatment of sepsis. Introduction: The purpose of this study is to evaluate the association between the development of hypercalcemia and the patient outcomes.

Methods: This single-center retrospective cohort study included patients aged ≥ 15 years admitted to the intensive care unit (ICU) of Osaka University Hospital between January 1, 2016, and December 31, 2018 (approval number: 20258). The hypercalcemia group comprised patients with ≥ 11.0 mg/dl serum calcium and/or albumin corrected calcium levels occurring even once in the ICU, while others were defined as the normal calcium group. All information were retrieved from the institutional electronic medical records. The primary outcome was ICU mortality. Data of the outcome variables and baseline characteristics of each group were compared using the Mann-Whitney U-test or Fisher's exact test. We used a propensity score (PS) matching by fitting a logistic regression model that was adjusted for age, sex, and the acute physiology and chronic health evaluation II score. We also compared hypercalcemia patients who died and survived in the ICU. All p values were 2-sided, and the level of significance was set at 0.05. Results: A total number of 2410 patients were investigated; of whom, 147 (6.1%) patients had hypercalcemia. The hypercalcemia group had a higher rate of ICU mortality than that of the normal calcium group (25.2% vs. 1.2%, p < 0.001) even after PS matching (25.2% vs. 4.8%, p < 0.001). The hypercalcemia group had higher rates of ICU morbidity and hospital mortality (p < 0.001 for all) (Table) . The patients of the hypercalcemia group who died in the ICU were found to have higher maximum calcium levels (12. 4 Introduction: Consecutive incident reports pertaining to patient handovers between our emergency department (ED) and inpatient wards prompted a quality improvement project using the ADaPT ® method. This led to a series of interventions aimed at improving handovers: a structured form within the electronic record; continued advocacy of the ISBAR structure; bedside handover; education; points of contact; and creating a positive environment to speak-up. Bedside handover was considered the most prominent change from current practice. Our study aimed to evaluate the effect of this project.

To evaluate the quality of patient handovers scoring tools were utilized, the Hasselt Instrument for Assessing Handover Quality (HIAHQ) and the Handoff Clinical Evaluation Exercise (handoff-CEX). The HIAHQ scores overall quality of patient handovers, whereas the handoff-CEX scores individual handovers. Both scoring tools were utilized before and after the implementation of abovementioned interventions. The HIAHQ was issued to all nurses concerned with patient handovers from the ED to inpatient wards. The handoff-CEX was made electronically available to both the ED and the ward nurse after a handover took place during two fortnight study periods. Results: A total of 191 HIAHQ assessments were collected, respectively 109 pre-intervention and 82 post-intervention. A total of 194 individual handover interactions were scored with the handoff-CEX. Data from the HIAHQ showed a significant improvement in the overall perceived quality of patient handovers both for the ED as well as the ward nurses. The assessment of individual handovers showed a significant improvement as well on all domains of the handoff-CEX tool. This effect was most outspoken for the ward nurses. Figure 1 shows a graphical representation of the abovementioned results. Conclusions: The ADaPT ® method, providing a tailor-made improvement program enabled a project team to significantly improve the quality of nursing handovers between the ED and inpatient wards. Introduction: Taking care of the elderly might be real challenge especially in the emergency department (ED). The noticed increase in lifespan during the last decades made it the job of health care providers to ensure a good quality of care provided for these subjects. However, in areas of low resources where geriatric departments are still lacking, managing this fragile category of the population might be an even harder job to do. The goal of our study was to establish the epidemiological characteristics, as well as to draw the pathological profile of these patients. Methods: This a prospective single-center study conducted in the ED of the Aghlabids Hospital, over a two-month period, from March 2020 till April 2020. We used SPSS22.0 for analytical analysis. Results: We enrolled 276 patients. There was a slight male predominance (56.88%, n = 157). Mean age was at 72 years ranging from 65 years till 97 years. One third of the patients presented at least one comorbidity. A number of 186 patients presented a Daily Activity living (ADL) scale > 3 which means 67.4% of the patients were not self-dependent. In our study, 76.81% (n = 212) of the patients were performed additional medical investigations. Urinary tract pathologies were most common (39%, n = 107) followed by locomotor system pathologies (20%, n = 55), and surgical pathologies (14.5%, n = 40). Only 3.5% (n = 10) of the patients were admitted to the resus room and only 1.25% (n = 3) of the patients needed urgent neurosurgical intervention. In our study, 56% of the patients were discharged to go home, while 44% of the patients were admitted to departments other than the ED. Conclusions: This study drew the particular and distinguished aspect of elderly patients who visit the emergency department. Trying to provide health care for such patients is challenging and requires a preestablished protocols. A geriatric department could also be a good idea since such departments are still lucking in areas of low resources such as Kairouan. Introduction: Patients with symptoms of pulmonary embolism (PE) are common in the emergency department (ED). Positive D-dimers (DD) often trigger emergency computer tomography (CT). With this study we aimed to address the dilemma between overuse of CT scans and fear of missed PE. To rule out PE, grant a high grade of security for the patients, reduce radiation, costs, and occupied beds, we evaluated a combination of age-and risk-adapted protocol. Methods: We performed a monocentric, retrospective study on patients tested for DD in order to diagnose PE between 01/2018 and 08/2018. We analyzed patients with DD between 0.5-1.0 mg/l, using age-adjustment (recommended by the guidelines) and risk-adaption with the Well's Score. In patients with DD ≤ 1 mg/l and the Well's Score of ≤ 4 diagnosis of PE deemed to be unlikely. The CT scans of these low-risk patients were re-read in detail. Results: Data on DD were raised in 1,270 patients in the examined period. We excluded 1,022 patients as DD tests were carried out for other reasons than PE, or DD values were below 0.5 mg/l or over 1.0 mg/l. 148 patients were included. PE was unlikely in 60 patients using age-adjustment for DD. PE was likely in 88 patients, in 19 patients a CT scan was not performed and had to be excluded. Only 7 out of 69 patients had a Well's score over 4 in the risk-adaption analysis. Of these 7 patients, 1 patient had a paracentral PE. Out of 62 low-risk patients, 2 patients had a subsegmental PE, 1 patient a known thrombus. This results in a reduction of 89.8% in scans in the analyzed cohort, missing 2 new minor PEs (3.2%). In the group who would have had a scan 1 out of 7 patients (14.3%) was diagnosed with a paracentral PE. Conclusions: The combination of age-and risk-adapted assessment in patients with suspected PE resulted in a convincing reduction of CT scans with a tolerable risk for missing PE. Introduction: Pulmonary embolism (PE) is a common complication of the coronavirus disease 2019 (COVID-19) and is associated with an increased mortality risk in hospitalized patients [1] . We conducted this study to assess the specificity of an elevated absolute D-dimer for PE in COVID-19 patients admitted to the ICU, as well as the specificity of a D-dimer increment in COVID-19 patients who developed PE during ICU-stay. Methods: We conducted a case-control study in patients with COVID-19 pneumonia admitted to our ICU. D-dimer values were paired with results of CT pulmonary angiograms (CTPA), and compared in patients with and without PE on admission. In patients without PE on initial imaging and available follow-up CTPA during ICU-stay, the D-dimer increment between initial and follow-up imaging was calculated. Patients that developed PE during ICU-stay were compared with those with persistently no PE. Results: Of 124 patients, CTPA on admission was performed in 100; PE was diagnosed in 22. D-dimer values were elevated in both groups, but more in those with proven PE (median 6060, IQR 1105-16,600 vs 850, IQR 492-1570 μg/l; p < 0.0001). Using the standard cut-off value of 500 μg/l, specificity was 27.3%, which increased to 100.0% when an adjusted cut-off value of 9000 μg/l was used. In 38 patients without PE on initial CTPA, follow-up imaging was obtained during ICUstay; PE was diagnosed in 21, increasing the overall incidence of PE in COVID-19 patients in our ICU to 34.7%. Patients that developed PE during ICU-stay showed a higher D-dimer increase than those who remained PE negative (median 8890 IQR 5640-19,000 vs 4970 IQR 1970-7803 μg/l; p < 0.01). Using a cut-off value of > 8000 μg/l for delta D-dimer, specificity was 100% in our study population. Conclusions: When adjusted cut-off values are used, routine measurement of D-dimer might aid clinicians in diagnosing pulmonary embolism in patients with COVID-19 pneumonia admitted to the ICU. Introduction: The COVID-19 epidemic has been developing in Tunisia officially since March 2, 2020. Since the spread of the epidemic, the governorate of Mahdia has experienced 23,271 cases of contamination including 673 deaths and 20,739 cases of recovery. The aim of this study is to describe the epidemiological and clinical characteristics of patients with COVID-19 who have been hospitalized in the emergency department of Mahdia. Methods: This is a retrospective study, carried out in the Emergency Department of Mahdia over a period of 12 months extending from September 2020 until August 2021. We included patients over 18 years-old hospitalized with COVID-19 lung disease confirmed either by RT-PCR or rapid antigen testing. For all patients included, demographic, clinical, biological and therapeutic data were collected as well as the patient's outcome. Results: A total of 976 patients were included, the mean age was 67. Patients over 70 years of age accounted for 40%. The sex ratio 1.06. 74.2% of patients had at least one comorbidity, including hypertension (52%) and diabetes (46%). The most frequent clinical sign was dyspnea (77%). Initial management included low flow oxygen therapy in 319 patients (33%), high flow oxygen therapy in 426 patients (44%). And 102 patients (10%) received non-invasive ventilation and 13 (1%) received invasive ventilation. Severe forms are frequent (43% of cases). Patients admitted to the emergency department only (360 or 37%), compared to those transferred to intensive care Critical Care (2022) 26:72 (209, 21%) and to the COVID department (373, 38%), were older [age average respectively: 73 years (SD ± 13); 66 (SD ± 13); 61 (SD ± 13); p = 0.001] and likely to have at least one comorbidity (79%, 76%, 73% respectively). The case fatality rate was 31.5% in all patients. Conclusions: In this study, our patients were mainly elderly, male, having at least one comorbidity with a high mortality rate, hence the need for a prospective study specifying the predictive factors of mortality. Conclusions: This descriptive retrospective study shows also a high mortality rate in the emergency department. These deaths could be avoided if the intensive care department accepted them, but the advanced age, several comorbidities, a severe clinical form were the reasons why the medical resuscitation department refused to take them in charge preferring to save the few places they have for patients with better prognosis. 

The COVID-19 pandemic, declared in March 2020, had a significant impact on the well-being of the general population around the world. The quarantine, isolation, restriction of activities and the economic crisis were at the origin of these mental health disorders. The aim of our study was to assess the COVID-19 pandemic psychological impact. Methods: This was a cross-sectional prospective that lasted one month starting from October 1, 2021. we interviewed the emergency department consultants and their companions. The Form included 23 items assessing the anxious and depressive symptoms by a score validated by the High Authority for Health. Results: We included 190 adults, the average age was 30 ± 10 years with a sex-ratio of 1.5, the majority (78%) were of university education, 17% had a secondary level of education. In our sample, 14.7% had a pathological history, 12.1% were on symptomatic treatment for psychiatric disorders, 10% were already followed by a psychiatrist. Half of the population had a COVID-19 infection, 77.4% had a parent or family member who was infected with COVID-19. Concerning the psychological impact 48.9% had signs of definite depression and 50.5% had signs of anxiety. A significantly higher level of anxiety in people who have had a member of the family infected with COVID-19 ( OR 2.99, IC 95% [1.44; 6.19]; p < 0.01). Conclusions: In this context of COVID-19 pandemic the psychological impact is almost inevitable and the fear of infecting and losing a loved one remains the most dreadful event. Introduction: COVID-19 is a pandemic declared in 2020, the gravity of which lies in the risk of developing a cascade of complications in 20% of cases, which can lead to death. These complications result from an inadequate immuno-inflammatory reaction. Several factors are predictive of severe forms and death. Taking into account these predictive markers will allow the classification of patients with COVID-19 and their optimal management. The aim of our study was to investigate the value of neutrophil-lymphocyte ratio (NLR) in predicting mortality of COVID-19 patients hospitalized in the emergency department of Mahdia. Methods: A retrospective cohort study including patients over 18 years old hospitalized in the emergency department with COVID 19 confirmed by either RT-PCR and or SARS-COV-2 Rapid Antigen Test, over a period of 9 months from September 2020 to May 2021. The parameters collected were: demographic, clinical, biological characteristics as well as patient outcome and hospital mortality. The NLR was calculated for all patients. Results: A total of 454 patients were included, the mean age of the patients was 67 years (SD ± 14), the sex ratio (M/W) was 1.11. In-hospital mortality was 34% (155 patients). On-admission NLR levels were significantly higher in the non-survivor group 14.4 (SD ± 15.0) compared to the survivor group 9.7 (SD ± 9.6) (p = 0.001). Although NLR differed significantly between the survivor and non-survivor groups, this ratio was not identified as a predictor of mortality in COVID-19 lung disease as the informational index study showed low sensitivity and specificity. Conclusions: Our study showed that on-admission neutrophil-lymphocyte ratio (NLR) was statistically higher in non-survivors patients, however we did not find a cut-off value that could discriminate between surviving and non-surviving patients with acceptable statistical significance.

H O'Neal 1 , R Sheybani 2 , T Caffery 3 , H Tse 2 , A Shah 2 , C Thomas 1 1 LSU Health Sciences Center / Our Lady of the Lake Regional Medical Center, Pulmonary & Critical Care Medicine, Baton Rouge, LA, USA, 2 Cytovale, LLC, Cytovale, San Francisco, CA, USA, 3 LSU Health Sciences Center / Our Lady of the Lake Regional Medical Center, Emergency Medicine, Baton Rouge, LA, USA Critical Care 2022, 26(Suppl 1): P059 Introduction: Sepsis, a common and fast-moving condition, often arises in the community, and presents to the ED where providers must perform the initial diagnosis for patients with signs of infection. Currently, a rapid diagnostic with clinically actionable performance is needed to assist ED clinicians in this task. The objective of this study was to assess the potential of the IntelliSep test when compared to commonly-assessed indicators of sepsis. Methods: Patients were prospectively enrolled at ICU admission with either suspected sepsis (cohort A; n = 52) or considered at-risk for sepsis (cohort B; n = 137); 11 patients initially enrolled in Cohort B subsequently suspected of sepsis and were moved to an additional crossover cohort. BVN/SEV-3 was measured from whole blood sample (via NanoString nCounter) at cohort enrollment. Likelihoods of bacterial and viral infection and illness severity were determined by BVN/ SEV-3 and its accuracy was compared with procalcitonin, IL-6, and sequential organ failure assessment (SOFA) scores. Introduction: Extracellular DNA (exDNA) fragments in plasma mediate intercellular signaling in critical illness contributing to systemic inflammation reactions. Most studied mechanism includes binding of exDNA to its receptor TLR9 to induce NFkB gene expression. Carriers of genetic variant CC of TLR9 rs352162 are predisposed to multiple organ failure and/or lethal outcome in post-trauma [1] , post-stroke [2] and sepsis [3] . In a novel study, we assess whether the concentration of exDNA in plasma may limit or reveal the predictive value of rs352162 TLR9 CC genotype in multimorbidity sepsis patients. Methods: The cohort included 110 post-surgery and diabetes patients with sepsis and multimorbidities (70% with cardiovascular diseases, hypertension, coronary artery diseases), Charlson index value, 7 (4-9), CIRS scale value, 23 (17-27). Circulating exDNA was isolated from plasma and quantified by CYBR Green dye. Genotyping of allelic variants CC, CT and TT of the TLR9 rs352162 polymorphism was performed using a PCR and allele-specific tetra primer set followed by electrophoretic separation of the PCR products. Statistical analysis was performed using SigmaPlot 12.5 software. The Shapiro-Wilk test was used to assess the normality of variable distribution in the groups. Significance between groups was evaluated by Chi-square with Yates correction, Fisher's test, Mann-Whitney test and One-was ANOVA. Results: Carriers of TLR9 CC rs352162 genotype exhibit significantly increased CIRS index for lower GI and hepatic/pancreatic comorbidities. Only subcohort of patients with exDNA > 100 ng/ml, however, exhibit significant association of TLR9 CC rs352162 genotype and increased risk for unfavorable outcome (odds ratio 6.4, 95%CI: 1.338-30.6) ( Fig. 1) , whereas no linking of TLR9 genotype and outcome are revealed in patients with < 100 ng/ml exDNA in plasma. Conclusions: Determining the polymorphism of TLR gene and exDNA concentration in plasma might aid in stratification of multimorbid sepsis patients in ICU for early personalized intensive care. Introduction: This study evaluated the usefulness and cost-effectiveness of procalcitonin (PCT) following its introduction to aid antibiotics discontinuation in critical care patients admitted to ESHT during the COVID-19 pandemic. Methods: Non-surgical critical care patients with a diagnosis of sepsis or lower respiratory tract infection during their admission between 01st January and 30th June 2020. Retrospective analysis of data using ICCA (IntelliSpace Critical Care and Anaesthesia) to compare the number of antibiotic doses administered per patient before and after introduction of PCT. After PCT introduction, we recorded the number of PCT levels requested, their frequency as well as the level of PCT and when discontinuation occurred. Results: A total of 81 patients were included-13 admitted before PCT introduction and 68 after (this important increase in the number of patients is explained by the increased proportion of patients with COVID-19 pneumonitis). The average dose of antibiotics administered per patient was reduced by 28.8% (70.24 vs 49.98) following introduction of PCT. Despite an incurred cost of £12 per PCT assay, the overall average cost per patient was reduced by £59.60 (£257.94 vs £146.78). A lack of consistency in the frequency of PCT level request was observed. Conclusions: Introduction of PCT to aid discontinuation of antibiotics resulted in a 28.8% reduction in average antibiotics prescription and an overall cost reduction of £59.60 per patient. The reduction in antibacterial exposure also brings non-financial benefits such as increased patient safety through experience of less side-effects, reduction in antibiotics resistance among others. The lack of consistency in the requests of PCT resulted in the design of a protocol for its use within ESHT.

Early prediction of sepsis in intensive care patients using a machine learning algorithm, a randomized clinical validation trial F Sjövall 1 , I Persson 2 1 Carl Bertil Laurells Gata 9, Intensive Care Unit, Malmö, Sweden, 2 Department of Statistics, Department of Statistics, Uppsala, Sweden Critical Care 2022, 26(Suppl 1): P064

The primary objective of this trial was to, in an ICU setting, externally validate the prognostic accuracy of a machine learning sepsis prediction algorithm that uses routinely collected vital parameters, blood gas values and lab values as input. An improved detection of sepsis will enable earlier treatment that may influence outcome. The tested algorithm has previously retrospectively demonstrated the ability to detect ICU patients at high risk of developing sepsis within the coming hours [1] . Methods: Adult patients admitted to the ICU at Skåne University Hospital Malmö from December 2020 to September 2021 were eligible for recruitment to the trial. A total of 305 subjects were randomized into one of two groups: Active algorithm, with sepsis alerts, or Standard of care. The algorithm made predictions in the whole cohort but was not displayed in the Standard of care group, in order to evaluate its performance without disturbing the outcome. The study was blinded, i.e. study personnel did not know for which subjects the algorithm was being used. The ICU followed standard practices in assessing possible development of sepsis and intervening accordingly. The subjects were followed in the study until ICU discharge. Results: The algorithm could identify patients with high risk of developing sepsis, with high performance (accuracy 0.79; sensitivity 0.80; specificity 0.78) for predictions 3 h before sepsis onset. Conclusions: The accuracy, sensitivity, and specificity were all high, validating the prognostic accuracy of the algorithm in an ICU setting. This is, as far as the authors are aware, the largest clinical trial ever conducted with a machine learning sepsis prediction algorithm, and the first one that clinically validates a sepsis prediction algorithm against the Sepsis-3 criteria. Introduction: COVID-19 is a severe respiratory disease associated with a marked inflammatory response. Clinical methods of assessing severity of disease, including National Early Warning Score 2 (NEWS2), have been shown to predict severity in COVID-19 [1] . However, little research has been undertaken comparing NEWS2 to underlying inflammatory processes. In this study, we assessed whether inflammatory markers taken at presentation to the Emergency Department could predict and mortality in COVID-19 patients. Methods: Whole blood samples were taken at admission to the emergency department for procalcitonin, fibrinogen, CRP, von Willebrand Factor (vWF), IL-6 and TNFα. NEWS2 was also recorded on admission. Levels of inflammatory markers were retrospectively compared to NEWS2 scores and mortality outcomes. Results: A total of 95 patients positive for COVID-19 were included. NEWS2 values > 5 were associated with higher CRP (131.5 ± 87.9 vs 86.4 ± 106.5, p = 0.03), IL-6 (71.9 ± 111 vs 43.4 ± 99, p = 0.007), and vWF (334.1 ± 83.3 vs 296.3 ± 93.4, p = 0.04). The trend of increasing inflammatory markers was also shown in patients who died, significantly so for IL-6 (44.4 ± 54.97 vs 18.8 ± 48.36, p = 0.035). NEWS2 was also shown to be significantly higher in patients who died (7.8 ± 2.2 vs 4.3 ± 2.8, p = < 0.01). Conclusions: NEWS2 predicted the severity of underlying inflammatory response. All inflammatory markers showed a marked increase with severity and mortality, most significant with IL-6. This suggests NEWS2 and inflammatory markers may predict severity and mortality in COVID-19 patients. Further research is required to evaluate these mechanistic changes in inflammatory response. Introduction: The Cardio-Vascular Index (CVRI) is a multi-vital sign index suggesting promising association with diverse conditions and morbidities along the entire hemodynamic spectrum [1] [2] [3] [4] . Our study aimed to evaluate CVRI predictability of death in septic shock. Methods: Dataset included adult patients stayed at Beilinson hospital ICU for more than 48 h (2012-2018). This study uses a cohort of 2,122 patients. CVRI patterns along 48 h from ICU admission were computed. Five machine learning (ML) classification algorithms were trained and tested for the development of prediction model of ICU mortality (Python software). We compared models using admission conditions only with models adding CVRI. Prediction performance was assessed by the receiver operating characteristics area under the curve (AUC) of ten-fold cross-validation and validation sets. The study was authorized by the local IRB. Results: In the cohort, the median (IQR) age was 63 (49-72) years, BMI 26 (23-31). Main admission conditions: surgical (40%), trauma (28%) and medical (21%). Septic shock was detected in 509 patients (24%). The best performing ML algorithm was Random Forest classifier. The model adding CVRI was preferable (AUC = 0.85) over model including admission conditions only (AUC = 0.77) (Fig. 1) . Conclusions: CVRI values of the first 48 h added to admission conditions were good predictors of death in septic shock. CVRI had an added value in predicting death over the existing admission conditions. This index may improve overall identification of high-risk patients. Introduction: Procalcitonin (PCT) is a widely used biomarker that helps to differentiate systemic inflammatory response syndrome (SIRS) from sepsis. PCT is increasingly used in emergency departments to differentiate between infective with non-infective exacerbation of COPD to guide antibiotic therapy [1] . D f is a functional biomarker that quantifies the incipient blood clots fibrin network across sepsis spectrum [2] . The aim of the study was to compare the changes in clot microstructure at different levels of PCT fractal dimension-d f . Patients were divided into five groups based on their PCT levels. Methods: A total of 85 AECOPD patients were recruited from the emergency department of a tertiary teaching hospital. Those patients who did not have PCT levels at admission were excluded. Blood samples were taken to perform fractal dimension (d f ) and PCT. The five groups based on PCT levels and what these levels indicates were < 0.05 ng/ml (no SIRS), ≥ 0.05 to < 0.5 ng/ml (SIRS), ≥ 0.5 to < 2.0 ng/ml (sepsis), ≥ 2.0 to < 10 ng/ml (severe sepsis) and ≥ 10 ng/ml (septic shock).

Results: The d f was highest at PCT level of ≥ 0.5 to < 2.0 ng/ml (Fig. 1 ). There was a significant correlation between d f at PCT at this level (p = 0.04). The d f was not significantly different between the five groups. Conclusions: Our results indicate that COPD patients develop denser and tighter clot microstructure as indicated by high d f when PCT levels are at a level consistent with sepsis. These changes in d f were previously demonstrated across sepsis spectrum. This study demonstrates the utility of d f to quantify clot microstructure across the sepsis spectrum in COPD patients particularly during exacerbations.

Performance of ED and discharge diagnosis of sepsis against objective assessments underscores the need for a reliable diagnostic H O'Neal 1 , R Sheybani 2 , T Caffery 3 , D Hamer 4 , D Burgin 4 , S Alwood 3 , T Jagneaux 1 , C O'Neal 5 , A Shah 2 , C Thomas 1 1 LSU Health Sciences Center / Our Lady of the Lake Regional Medical Center, Pulmonary & Critical Care Medicine, Baton Rouge, LA, USA, 2 Cytovale, LLC, Cytovale, San Francisco, CA, USA, 3 LSU Health Sciences Center / Our Lady of the Lake Regional Medical Center, Emergency Medicine, Baton Rouge, LA, USA, 4 LSU Health Sciences Center / Our Lady of the Lake Regional Medical Center, Internal Medicine, Baton Rouge, LA, USA, 5 LSU Health Sciences Center / Our Lady of the Lake Regional Medical Center, Infectious Diseases, Baton Rouge, LA, USA Critical Care 2022, 26(Suppl 1): P068 Introduction: Despite increasing awareness of and consensus guidelines for the treatment of sepsis, there is no reference standard for its diagnosis. Clinical diagnosis at presentation is difficult, resulting in heterogeneity in outcome reporting and trial performance when these diagnoses are used as classifiers. Methods: Adult patients presenting to the ED with signs or suspicion of infection were prospectively enrolled at multiple sites in the USA (Feb. 2016-Sept. 2019) in four discrete but similar cohorts. We compared different standards for sepsis diagnosis (ED Diagnosis, Discharge Diagnosis, and an Objective Assessment) with a reference standard of retrospective physician adjudication. ED diagnosis and Discharge Diagnosis were recorded from the medical record. Objective Assessment for sepsis was based on evidence of an infection defined by modified CDC surveillance definitions and an increase in SOFA of 2 or more points over baseline during any of the first three days of hospitalization. Results: A total of 678 subjects were included in the final analysis with a sepsis prevalence of 17.8% by the adjudication standard. Table 1 includes a comparison of ED diagnosis, discharge diagnosis, and objective assessment of sepsis in predicting adjudicated sepsis. While ED and Discharge Diagnoses performed similarly in comparison to physician adjudication, Objective Assessment had a significantly higher diagnostic odds ratio than either. In general, treating clinicians are more likely to over-diagnose sepsis. Conclusions: Treating clinicians are biased toward the over-diagnosis of sepsis, making ED and Discharge Diagnosis less reliable than an Objective Assessment, thus impacting outcome data and trial performance and underscoring the need for a reliable diagnostic biomarker for sepsis at ED presentation. It took a median time of 5 min (5-10) for ROTEM ® and 10 min (10-10) for TEG ® to achieve interpretable results. Assessment for hyperfibrinolysis took a mean time of 60.0 ± 0.0 min for ROTEM ® and 50.6 ± 5.8 min for TEG ® . There were significant positive correlations between platelet and CRT A10 (correlation coefficient, r = 0.86), and between fibrinogen and CFF A10 (r = 0.77) of TEG ® (Fig. 1) . ROTEM ® showed similar findings, with EXTEM A5 correlating well with platelet (r = 0.90), and FIBTEM A5 with fibrinogen (r = 0.81). The correlation between VHAs and clotting time were less optimal. Conclusions: There was good correlation between VHAs and platelet and fibrinogen levels in patients with sepsis, with a much shorter turnaround time. Introduction: COPD is a chronic inflammatory condition that leads to lung parenchymal changes and microvascular damage. There is an increased incidence of venous thromboembolisms and in particular pulmonary embolism during exacerbations (15-30%). The aim of the study was to investigate whether there is a difference in clot microstructure between stable (SCOPD) and acute exacerbations of COPD (AECOPD) using the functional biomarker fractal dimension (d f ) [1] . Methods: A total of 30 ambulatory SCOPD patients were recruited from the chest clinic and 85 AECOPD were recruited from the emergency department of a tertiary teaching hospital. Blood samples were taken to perform fractal dimension (d f ), full blood count (FBC), platelet aggregometry, PT, aPTT, fibrinogen, D-dimer, procalcitonin (PCT), CRP and Factor XIII.

The mean d f in stable COPD patients was 1.69 ± 0.05 when compared to 1.71 ± 0.06 (p = 0.02). The time to gel point (T GP ) that indicates the time for the initiation of blood clot was significantly lower in AECOPD group (327 ± 88 vs 275 ± 73, p = 0.004). Inflammatory markers such as CRP, PCT, WBC and Neutrophils was significantly higher in AECOPD group. D-dimer was significantly higher in AECOPD group however, FXIII was significantly lower in AECOPD group. FBC and platelet aggregometry was not statistically significant between the two groups ( Fig. 1) . Conclusions: COPD patients during exacerbations develop a profound inflammatory response which is associated with tighter and denser clot microstructure as indicated by significantly increased d f . We have previously reported similar findings in sepsis. Therefore, d f could be used to assess the underlying inflammatory effects of COPD on patient's clotting profile and future anticoagulant therapy. Introduction: The FiiRST-2 study will investigate whether fibrinogen concentrate (FC) and prothrombin complex concentrate (PCC) given ≤ 1 h after hospital arrival is superior to the standard of care in bleeding trauma patients. Bleeding coupled with acute trauma coagulopathy (ATC) is a leading cause of in-hospital mortality in trauma. Acquired fibrinogen deficiency and impaired thrombin generation are major drivers of ATC. Prompt and targeted coagulation factor replacement with FC and PCC may be superior to the current standard of care, a ratio-based plasma resuscitation via a massive hemorrhage protocol (MHP). Methods: FiiRST-2 is a randomized, parallel-control, superiority trial with an adaptive two-stage design, performed in 11 Canadian Level One Trauma Centers. Bleeding trauma patients > 16 years old (N = 350) will receive FC + PCC or a minimum 2:1 red blood cells (RBCs):plasma transfusion plus platelets, until the second MHP pack has been given, MHP is terminated, or 24 h has elapsed from admission ( Fig. 1 ). Exclusion criteria include receipt of > 2 units RBCs before randomization, > 3 h elapsed from injury, catastrophic brain injury, or known bleeding disorders. The primary endpoint is superiority in the number of composite allogeneic blood product units transfused ≤ 24 h after admission. Secondary endpoints include RBC units transfused ≤ 24 h after admission, ventilator-free days, and 28-day mortality. Adverse and serious adverse events, including thromboembolic complications, will be assessed through 28 days. Results: FiiRST-2 has enrolled 60 patients at 4 sites to date. An interim analysis will be performed after 120 patients have completed the study. Completion is expected in Q1 2023.

The FiiRST-2 study will determine if early use of factor concentrates (FC + PCC) is superior to the standard of care in bleeding trauma patients. Results could have a major impact on clinical practice, improving management and outcomes for this high-risk patient population. Introduction: While empiric dosing of fibrinogen replacement is widely utilized and well-tolerated, it may be suboptimal in some cardiac surgery patients, leading to inadequate bleeding control due to acquired hypofibrinogenemia. This may lead to additional transfusion requirements, impacting clinical outcomes. Our aim was to compare the efficacy and safety of weight-adjusted vs. empiric dosing of fibrinogen replacement. Methods: This post-hoc analysis of the FIBRES randomized controlled trial included adults experiencing clinically significant bleeding and hypofibrinogenemia after cardiac surgery at 11 Canadian centers and utilized empiric dosing of fibrinogen concentrate (FC; Fibryga ® , Octapharma; 4 g) or cryoprecipitate (10 IU) [1] . Patients were grouped into quartiles based on increasing weight-adjusted dosing of either product. The primary outcome was the number of red blood cell (RBC) units transfused within 24 h of cardiopulmonary bypass (CPB). Results: The median weight-adjusted FC dose was 52 mg/kg (IQR 45-61; n = 372) and 1.30 U/10 kg (IQR 1.11-1.54; n = 363) for cryoprecipitate. In patients receiving a single dose of either product where plasma fibrinogen level was measured pre and post dosing, the increase in plasma fibrinogen was higher with FC (0.96 g/l, IQR 0.74-1.28; n = 252) vs. cryoprecipitate (0.78 g/l, IQR 0.52-1.00; n = 225; p < 0.0001). There was no difference between patients in the quartile receiving the lowest weight-adjusted doses compared to higher quartiles in the number of RBCs (Table 1) or allogenic transfusions received within 24 h of CPB, return to the operating room, or thromboembolic/ischemic complications within 28 days. Conclusions: Transfusion and safety outcomes for low and high weight-adjusted doses of fibrinogen replacement were comparable. Weight-adjusted dosing does not appear to offer advantages over fixed dosing in hypofibrinogenemic bleeding adult cardiac surgical patients. Introduction: The CRASH2 trial [1] was previously conducted to estimate the effect of early administration (< 8 h from injury) of tranexamic acid (TXA) on outcomes such as mortality in a cohort of n = 20,21 bleeding Introduction: Key therapeutic goals in patients with acquired thrombotic thrombocytopenic purpura (aTTP) are to rapidly control platelet consumption and maintain durable remission. In the Phase 3 HERCU-LES trial (NCT02553317), caplacizumab (CPLZ) treatment resulted in significantly faster time to platelet count normalization versus placebo (PBO). Aim: to characterize the durability of platelet count responses in the HERCULES trial. Methods: This was a post hoc analysis of the HERCULES intent-totreat population (CPLZ, n = 72; PBO, n = 73). We identified patients with fast platelet count response and described the exacerbation rate. Time to durable platelet count response, time to complete remission (CR), and recurrence-free survival (RFS) were calculated. Results: Most patients achieved initial platelet count normalization ≤ 3 days (CPLZ, 56/72 [78%]; PBO, 43/73 [59%]). In patients with fast platelet count response (≤ 3 days), exacerbation rate was 4% (2/56) with CPLZ and 44% (19/43) with PBO. In patients with time to platelet count response > 3 days, exacerbation rate was 7% (1/15) with CPLZ and 30% (9/30) with PBO. Of patients who had exacerbations, 90% (CPLZ, 2/3; PBO, 26/28) switched to open-label CPLZ, which may have favored outcomes of PBO patients. Median (95% confidence interval) time to durable response was 4.5 (4.4-4.6) days with CPLZ and 10.5 (6.5-14.5) days with PBO (Fig. 1A) ; median time to CR was 40.0 (37.7-41.1) days with CPLZ and 44.2 (42.0-48.2) days with PBO (Fig. 1B) . Overall RFS during the study period demonstrated early and sustained benefit for CPLZ over PBO (Fig. 1C) . Conclusions: CPLZ was associated with a faster and sustained platelet count response versus PBO, where many fast responders subsequently had an exacerbation. Fast platelet count responses with CPLZ were maintained and translated into clinically relevant improvements in time to CR and overall RFS. This study and editorial support funded by Ablynx, a Sanofi company. Previously presented at 25th EHA Congress and 62nd ASH Meeting. Introduction: Patients with trauma are at high risk for venous thromboembolism (VTE) [1] . AntiXa (aXa) monitoring of prophylactic low molecular weight heparin (LMWH) is recommended by the 2002 EAST guidelines following initiation of therapy or after dose changes in some patients [2] . This study evaluates the efficacy of a pharmacistled protocol for enoxaparin dose adjustment based on aXa levels in trauma patients. Methods: This single-center retrospective chart review included adult trauma patients admitted from 3/1/2018 to 6/20/2020. Patients received LMWH per protocol based on body mass index (BMI). Patients with BMI < 40 kg/m 2 received enoxaparin 30 mg twice daily, and patients with BMI ≥ 40 kg/m 2 received enoxaparin 40 mg twice daily. The goal therapeutic range based on peak level was 0.2-0.4 IU/ml. The primary objective was time to goal peak aXa level after enoxaparin initiation. Secondary objectives include enoxaparin dosing regimen in milligrams and milligrams per kilogram, number of adjustments to reach goal level, rates of VTE, and rates of bleeding attributed to enoxaparin.

Time to durable platelet count response was defined as time to last daily TPE during the overall treatment period. Time to complete remission was defined as platelet count > 150×10 9 /l and lactate dehydrogenase < 1.5× the upper limit of normal for > 30 days after cessation of daily TPE. Recurrence-free survival was defined as absence of exacerbation or relapse during the overall study period. TPE, therapeutic plasma exchange. Hospital length of stay was significantly longer in PV (median 21.5 days vs 11.0 (p < 0.0001)). The PV group were sicker, with lower pH, higher lactate, higher dosing of vasopressor infusions and higher APACHE II score. 31% met criteria for moderate or severe ARDS. Receipt of blood transfusion (13%) and vasopressors (93%) were common (Table 1) .

Conclusions: There no guidelines to inform decisions about PV following emergency laparotomy. Perhaps the most robust indication for PV is significantly impaired oxygenation or inadequate ventilation. Patients arriving out of hours were more likely to remain ventilated, the risks of extubation may not be greater [2] . Adverse outcomes in the PV group are likely to be influenced by the reasons for PV, however it's conceivable that in itself PV could have a significant influence on outcome, and deserves further study. -To develop tools to facilitate the exploration and assessment of potentially hazardous inhabited spaces. -To improve the safety and efficiency of first responders [2] .

The INTREPID project is based on the collaborative work of research, technology and communications organizations focus on technology development within drones and robots unmanned. This tolls are testing by European emergency services.

-Mobile platform for scanning and assessment of a disaster area, for multidisciplinary teams -Drones and robots that will act as cybernetic assistants.

-Positioning, mapping and environmental assessment module. -Tactical communications system for disasters.

The first testing exercise was developed in Stockholm [2] :

-Metro flooding on 2 November 2021 Results: Key Performance Indicators [2] . Unmanned aerial vehicles have been tested in emergencies indoor with these new capabilities. Conclusions: Innovation with information technology (ICT), building sensors, mixed reality and autonomous vehicles, increases the efficiency in the attention to major catastrophes. Effective inter-group communication, obtaining information in real time and coordination through technology adapted to our needs, helps to reduce the initial chaos of the catastrophe, improve our assistance to patients and increase our safety in the intervention [2] . Introduction: Decision fatigue is a crucial concept in the intensive care unit (ICU) setting; it is the idea that after making many decisions, a person's ability to make additional decisions becomes worse. ICU consultants make numerous high consequence decisions on patients with complex pathology in time-critical scenarios. The aim of the study was to identify the density of decision making and its consequences on the quality of the decisions made by ICU consultants in our unit. Methods: This study took place across four twenty-four-hour on-call periods. Each consultant was monitored by a dedicated ICU trainee who recorded the daytime data. Demographic variables included the age, seniority of the ICU consultants, acuity of patients on the unit and and they felt more sufficiently trained (RR 1.5, p = 0.046). ED nurses felt less committed towards patient care when compared to non-critical care nurses (RR 0.9). ED nurses felt the hospital was less prepared to deal with continuing outbreaks when compared to non-critical care nurses (RR 0.5). On other subjects ED nurses did not differ significantly.

The psychological impact of the COVID-19 pandemic seems to be worse on our ICU nurses when compared to ED nurses and non-critical care nurses. The impact of the pandemic seems to be more traumatic causing more sadness among our ICU nurses with less active leisure activities. Our ED nurses on the other hand feel the hospital is less prepared for ongoing outbreaks and feel less motivated to continue care. Introduction: Burnout syndrome (BOS) has been recognized for over 50 years. Over time, it has been reported that certain health care specialties are more vulnerable to BOS, such as those working in an intensive care unit (ICU). The introduction of extracorporeal membrane oxygenation (ECMO) and its growing demand, adds to the overall workload in ICU, and exposes practitioners to complex ethical and administrative situations, which may impact their psychological well-being. We aim to investigate the effects of an ECMO service, on BOS development in the ICU. Methods: We conducted a cross-sectional descriptive study, using an online questionnaire; The Maslach Burnout Inventory Human Services Survey for Medical Personnel. In addition, demographic variables, workload, salary satisfaction, and caring for coronavirus disease 2019 (COVID-19) patients were assessed. Participants were divided based on working in ICU with ECMO service into ICU with (ECMO-ICU) and without (non-ECMO-ICU) ECMO service, and burnout status (burnout and no burnout). Results: The response rate for completing the questionnaire was 36.4% (445/1222). Males represented 53.7% of the participants. The overall prevalence of burnout was 64.5%. The overall burnout prevalence did not differ between ECMO-and non-ECMO-ICU groups (64.5% and 63.7, respectively). However, personal accomplishment (PA) score was significantly lower among ECMO-ICU personnel compared to those in a non-ECMO ICU (42.7% versus 52.6, p = 0.043). Significant predictors of burnout included profession (nurse or physician), acquiring COVID-19 infection, knowing other practitioners who were infected with COVID-19, salary dissatisfaction, and extremes of workload. Conclusions: Burnout was equally prevalent among participants from ECMO-and non-ECMO ICU, but PA was lower among participants in ICU with an ECMO service. The reported high prevalence of burnout, and its predictors, requires special attention to try and reduce its occurrence. from March 2020 to May 2021. Data collected daily from admission until death or discharge from ICU. Results: A total of 261 patients with severe acute respiratory distress syndrome coronavirus 2 (SARS-Cov-2) required admission to our intensive care. ICU facilities required expansion into a total of 5 Intensive Care Units, therefore reaching a capacity of 44 intensive care beds during the peak month of March 2021. A maximum of 21 patients were admitted per week culminating to a total of 33 COVID-19 Intensive Care beds during the month of March 2021. A total of 179 patients (68.6%) required mechanical ventilation for a median duration of 11 days per patient. Proning was required in 124 mechanically ventilated patients (70.5%). 50 patients (20%) required CRRT with a maximum number of 7 patients per day requiring CRRT. Conclusions: COVID-19 pandemic transformed the way how we provide critical care with improved bed capacity, ICU triage and ICU devices. This study highlighted the need for more clinical guidelines and their availability for online use. This will positively impact the care of non-COVID patients. It also highlighted the need for more training of non-ICU staff to allow for surges in ICU capacity. The COVID-19 pandemic has seen Mater Dei hospital already investing in ICU personnel and equipment as this cannot be reactive to large scale events but must be a proactive planned strategy to enhance resilience of our ITU. 4.5-6.3] in the HC. Basal platelet respiration did not differ substantially between the three groups, whilst PBMC basal respiration was increased by approximately 80% in the T1 group when contrasted to T2 and the HC. fMtDNA was 14 times higher in the T1 group and 5 times higher in the T2 group when compared to the HC. Conclusions: fMtDNA levels were increased in COVID-19 patients, but were not associated with decreased mitochondrial O 2 consumption in vivo in the skin, and ex vivo in platelets or PBMC. This suggests the presence of mitochondrial stress, with concurrent preservation of mitochondrial respiration and function. It must be noted that due to the timing of T1, the optimal measurement window could have been missed. Therefore, the role of mitochondrial dysfunction in COVID-19 should be further evaluated at different time points. Results: Patients with ARDS differed from the non-ARDS group ones in reduced lymphocyte count (p = 0.014), increased neutrophil count (p = 0.049), and neutrophil-to-lymphocyte ratio (NLR) (p = 0.002). During days 6 to 20 of hospitalization, a higher NLR was detected in ARDS patients compared with non-ARDS patients (Fig. 1A) . Analysis of TREC/KREC levels both per 100,000 cells revealed significant differences: TREC/KREC values were lower in the group of ARDS patients; these differences persisted after adjustment for multiple comparisons (Fig. 1B) . The TREC/KREC levels were also lower in non-survivors than in survivors. TREC/KREC negatively correlated with NLR; the highest correlation was recorded for TREC per 100,000 cells (Spearman's rho = − 0.726, p = 1.0 × 10E-06, coefficient of determination R 2 = 0.527). Conclusions: Thus, TREC/KREC analysis is a potential prognostic marker for assessing the severity and outcome in COVID-19. Introduction: Critical care nosocomial infection (CCNI) increases risk of patient mortality and morbidity [1, 2] . The impact of the Coronavirus 19 (2019-nCoV) pandemic on CCNI in terms of increased strain and infection control measures, is uncertain. Departmental strain has the potential to confound impact of infection control measures aimed to reduce CCNI incidence. This study will describe the impact of 2019-nCoV on non-COVID CCNI incidence and mortality. Methods: A retrospective cohort study of adult patients admitted to critical care in one Central London teaching hospital. CCNI incidence, (diagnosed ≥ 48 h post critical care admission), was compared between pre (Jan 2019-Feb 2020) and peak COVID (Mar 2020-Jun 2020). Results: Of 2,266 patients, 1788 were admitted pre and 478 peak COVID. Mean age was 57.2 years and 56.1 years pre and peak COVID respectively, with 35.5% and 37.4% of patients, female. There was a significant increase in rate of total CCNI incidence (1.6% to 3.6%) in the pre and peak period respectively. There was a significant increase in rate of incidence of gram negative bacterium and C. diff, but not in gram positive bacterium, MRSA, VRE and fungus. The increase in rate of peak (23.5%) compared to pre COVID (13.5%) CCNI non-COVID mortality, was not significant ( Conclusions: Culture positivity is a strong prognostic indicator of inhospital mortality for COVID-19 sepsis patients and warrants investigation as a candidate variable for future clinical outcome algorithms. Introduction: Organising pneumonia (OP) diagnosis is histological, however may be inferred by CT pattern [1, 2] . OP due to COVID-19 has been reported but its role remains unknown. Methods: A single-centre, ethical commission approved, retrospective study was conducted in a tertiary university hospital. Data was collected from patients admitted to ICU with severe COVID-19 between March 2020 and February 2021. OP was defined according to CT chest findings. OP patients were treated with 1 mg/kg/day methylprednisolone as per our protocol. Data was analysed using STATA 15.1. Results: We included 338 patients admitted due to COVID-19 pneumonia, mainly male (68%) with mean age 65.0 ± 13.1 years, 71% underwent invasive mechanical ventilation (IMV) for a median time of 13 days and 84% received corticosteroid treatment, 107 dexamethasone only, the remainder methylprednisolone. 126 patients (37%) featured CT compatible with OP. There were no differences between OP and non-OP regarding age, gender, SAPSII or comorbidities. Although patients with OP more frequently underwent IMV (p < 0.01), time from symptoms until IMV was longer (10.1 ± 6.1 in C vs 11.9 ± 6.1 days, p = 0.02). Interestingly, duration of IMV and length of stay (LOS) were increased in the OP group (24.5 ± 20.7 vs 14.2 ± 13.9 days, p < 0.001; LOS: 28.2 ± 27.6 vs 14.4 ± 15.6 p < 0.001), although no difference in ICU (30% vs 29% in OP) or hospital mortality ( 42% vs 53% in OP, p = 0.126) was observed. Not surprisingly, delirium (22 vs 36%, p = 0.01), ICU acquired weakness (20 vs 43%, p < 0.01) and nosocomial infections (41vs 69%, p < 0.01) were more frequent in OP patients. Of note, 87% versus 45% of C patients were still on corticosteroids at the time of ICU discharge. Conclusions: High prevalence of OP was demonstrated in this severe COVID cohort associated with longer IMV time but not a significant increase in mortality. More data is required to determine adequate treatment and impact on prognosis. Introduction: This study aimed to determine the mortality and morbidity of COVID-19 patients in an intensive care unit (ICU) until hospital discharge, and explore the factors that influence in-ICU and in-hospital mortality rates. Methods: Single center retrospective cohort regarding COVID-19 critical patients in a tertiary hospital ICU, from September/20 to June/21. Demographic data, clinical characteristics, admission SOFA score, frailty score (FS) and clinical management were analyzed. Results: We included 159 consecutive COVID-19 critical patients. The median (IQR) age was 66(57-72); 101(63.5%) were male. A total of 126 (79.2%) patients received hospital discharge, ICU-mortality rate was 18.9%(30 deaths). The median (IQR) ICU length of stay was 12 days (6-20) and in-hospital stay was 21(13-35), and no significant differences were found in ICU and in-hospital length of stay between survivors and non-survivors. At admission to the ICU total SOFA score was 4(3-7). In univariate analysis, increased age, higher admission SOFA score, acute kidney injury and acute neurologic disfunction at admission were significantly associated with increased hazard of mortality. The need for mechanical ventilation were associated with higher risk of ICU and in-hospital mortality. Previous comorbidities (hypertension, diabetes, obesity, heart failure, COPD, renal, hepatic, oncologic or immunosuppression) or the FS were not significantly associated with in-hospital mortality. None of the COVID-19 pharmacologic treatments (remdesivir, steroids and tocilizumab) were significantly associated with in-hospital mortality. In a multivariable analysis with in-hospital death as the dependent variable, a 10 year increase in age was associated with a mortality OR of 2.9 (95 CI:1.5-5.5)( p = 0.002) and the development of shock during ICU stay was associated with a mortality OR of 8.8 (95 CI:1.5 to 53.3). Conclusions: In this cohort, only age and the development of shock during ICU stay were independently associated with higher risk of inhospital death. 

The cause of respiratory distress by the novel corona virus is an acute hyper inflammatory "cytokine storm". Besides glucocorticoids, tocilizumab, a recombinant monoclonal antibody, directed against the IL-6 receptor, has been used as a treatment modality with variable results [1] . Factors affecting poor response to tocilizumab remain unrecognized. We report a model to predict worse outcomes among patients with severe COVID-19 pneumonia treated with tocilizumab.

Methods: In this retrospective study, patients with severe COVID 19 pneumonia admitted to the intensive care unit of our hospital who received Inj. tocilizumab besides the standard treatment between July 2020 to July 2021, were included. Electronic records of such patients were accessed and demographic, biochemical and outcome measures were recorded. Patients were divided into survivor cohort and mortality cohort. To predict mortality as an outcome, a multivariate logistic regression model was constructed. Results: Total of 101 patients were included, 71 in survival cohort and 30 in mortality cohort. Lactate dehydrogenase (LDH), neutrophil to lymphocyte ratio (NL ratio), creatine kinase myocardial band (CKMB) and partial pressure of oxygen to fraction of inspired oxygen ratio (PFR) on day of drug administration differed significantly among the two cohorts after correction for multiple comparison. However, on multivariable logistic regression analysis, a model incorporating LDH, NL ratio, pro-brain natriuretic peptide levels (ProBNP) and PFR best predicted mortality (Fig. 1) . A nomogram was also created to estimate probability of mortality using the model parameters.

Conclusions: LDH, ProBNP, NL ratio and PFR at Tocilizumab administration are independently associated with mortality. A model incorporating the combination of these parameters at admission can predict mortality among patients with severe COVID-19 pneumonia with good accuracy. Time on ventilator, LOS in ICU and mortality were significantly higher in suspected PF patients than in no suspected PF patients, with no differences between the cohorts (Fig. 1) . Conclusions: Increased circulating fibrosis markers reflect development of PF in critically ill COVID-19 patients, which is associated with prolonged ICU length of stay and high mortality rates. Introduction of dexamethasone as standard-of-care is not associated with altered incidence of PF or improved clinical outcomes in patients with PF. The aim of this study was to improve treatment of corticosteroid induced hyperglycaemia in patients critically unwell with COVID-19. Management with high dose steroids reduces mortality and has become standard practice. However, high dose glucocorticoid therapy impairs glucose metabolism in patients already at risk of insulin resistance and impaired insulin production, resulting in increased incidence of hyperglycaemia [1] . ) UTI, 6 (9.5%) CVC associated infections and 3(4.8%) soft skin tissue infections. In univariate analysis, both SOFA score at admission (p < 0.001), acute cardiovascular (p = 0.003) and neurologic (p = 0.006) disfunction at ICU admission were associated with the development of AI. AI were also correlated to need of tracheostomy(p < 0.001), development of delirium (p < 0.001) or shock (p < 0.001); and with longer ICU and in-hospital stay (p < 0.001) and ICU and hospital mortality (p = 0.011 and p = 0.011, respectively). None of the COVID-19 pharmacologic treatments considered (remdesivir, steroids and tocilizumab), neither different regimens of ATB therapy at ICU admission were significantly associated with AI. Conclusions: In this cohort, almost 40% of the patients developed AI, that was associated with 4 times higher hazard of needing mechanical ventilation and higher rate of adverse events such as delirium, shock during in-ICU stay and longer length of ICU and in-hospital stay. Introduction: Patients admitted to intensive care with severe SARS-CoV-2 infection frequently present with sepsis. These patients are at a higher risk of developing a secondary infection, but this can be difficult to distinguish from the primary viral infection [1] . Liberal use of broad-spectrum antibiotics can lead to proliferation of antimicrobial resistant organisms. We aimed to identify the rates of bacterial secondary infections and antimicrobial usage in critically ill COVID-19 patients.

We performed a retrospective review of case records for patients admitted to critical care from three hospitals in the Greater Glasgow and Clyde Health Board, Scotland. Patients with confirmed SARS-CoV-2 infection admitted to high dependency or intensive care were eligible. We collected data on background patient demographics, comorbidities, admission SOFA scores, antimicrobial usage, and positive microbiological cultures from within a 10-day period. Cultured organisms that were unlikely to be clinically significant were excluded. [2] . The mortality rate was 34%. All patients received corticosteroids, and 74% were treated with an IL-6 receptor antagonist. Half of the patients had at least one clinically significant positive microbial culture, however a much higher proportion (73%) were treated with antibiotics.

Conclusions: Secondary infections can be difficult to diagnose in the presence of severe COVID-19 disease, with a disproportionally high use of antibiotics relative to positive cultures. Additional diagnostic tools would be useful in this patient population to aid in antimicrobial stewardship. Introduction: This study aims to evaluate the impact of ventilatoracquired pneumonias (VAP) on the patient and healthcare system in Portuguese ICUs. VAP is associated to increased patients' length of stay (LOS), as well as prolonged periods of mechanical ventilation(MV), responsible for a fraction of antibiotic prescriptions. This study compared demographic characteristics of MV patients who developed VAP versus patients who did not. Methods: This study included adult subjects, admitted to ICU for any reason between July 1, 2016 and December 31, 2017. Only subjects who started MV for at least 48 h during their ICU admission were included. VAP patients and MV patients who did not develop VAP (MVnon-VAP) were identified retrospectively and randomly included in a 1:1 ratio. Demographic information, VAP-related characteristics, and baseline severity scores were captured from medical records. Results: 197 VAP patients and 197 MVnon-VAP patients were included. A larger number of patients (46.7%) in the MV non-VAP group were aged 70 years or older, p = 0.021. The main reasons for ICU admission were different between groups. Differences were also observed in severity scores between VAP and non-VAP patients (SAPSII, p = 0.048) (Fig. 1) . On healthcare resource utilization, statistical differences (p < 0.001) were observed between VAP vs MVNon-VAP patients in hospital (61 vs 35.9 days, respectively) and ICU LOS (27.5 vs 11 days, respectively). Also, MV duration was always higher for VAP patients (20.7 vs 8 days, respectively, p < 0.001). Conclusions: Among MV patients, VAP group experienced more hospitalizations and longer LOS, supporting a large healthcare resource utilization required by VAP which might lead to higher admission costs. Several limitations must be considered in this retrospective study including the different criteria associated to VAP diagnosis in each center. Nevertheless, these data reinforce the importance of characterizing adequately hospital infections, for an improved management and optimize health resources. Conclusions: CAPA is a severe complication and entails significant increase in morbi-mortality. We implemented an active surveillance system in our ICU. Early and timely detection, together with optimal organ support management could have influenced clinical outcomes, lowering the ICU mortality rate. In our sample, this mortality is not statistically significant despite being higher than in the non-CAPA group. It is possible that this difference was not greater, thanks to the proposed active surveillance protocol. (Fig. 1) .

This study underlines the variable impact of pre-admission versus critical care acquired pathogens on patient outcomes and impact on critical care patient care and costs. This study reinforces the importance of optimal pre-admission and critical care infection control procedures to reduce excess critical care mortality, LOS and cost. Introduction: Multiresistant bacteria (MRB) increases the patient's morbimortality rates, particularly in the critically ill. The choice of a correct empirical antibiotic may reduce the impact of these infections and the disseminations in our units. Methods: Analysis of a prospectively database (ENVIN HELICS registry)12 months (year 2018) in our ICU. We registered all + cultures with ESKAPE germs (Enterobacteriae, SARM, Klebsiella, Acinetobacter, Pseudomona, Enterococcus) and divided in 2 categories: "colonization culture" and "suspected infection". From all "suspected infection" registered the empirical antibiotic therapy used. When the microorganism was identified, analysed if the antibiotic was either maintained, changed or added a 2º one. With the antibiogram defined whether the empirical treatment was appropriate or not. Introduction: COVID-19 has generated enormous difficulties globally due to the high number of critically ill patients and uncertainty of the best therapeutic approach, even after 18 months of pandemic and multiple clinical trials. The antiviral remdesivir (RDV) has shown to reduce time to clinical recovery and, in a subgroup with low flow O2 at time of drug initiation, to reduce mortality by 70% (ACTT-1) . Subsequent openlabel RCT, Solidarity and Discovery, didn't confirm these findings. In our unit, a strict protocol was used, including a 5-day cycle of 20 mg dexamethasone and start of HFNC/CPAP when increased work of breathing became noticeable, along with prolonged periods of awake prone position. The use of RDV was a point of significant variability, allowing us to compare outcomes. We describe our unit's experience and RDV impact on patients under non-invasive ventilation (NIV (Table 1) . We observed also that cerebral edema and 3-4 HE were more frequent in non-survivors compared to survivors respectively 45% vs 20%. Fibrinogen was significantly reduced in non-survivors compared to survivors, respectively 0.89 g/l±0.11 vs 2.1±0.59 p < 0.0001.

We observed that these parameters, particularly the combination of lactate [1] , serum creatinine, ammonia is of great importance to identify early, patients who will not survive with medical therapy and so to select potential candidates for liver transplantation.

Introduction: During recent years the evolution of systemic inflammation in patients with progressing hepatic decompensation and acute-on-chronic liver failure (ACLF) has been recognized and identified as an important trigger of extrahepatic organ failures [1] [2] [3] . In theory one assumes that reduction of pro-inflammatory cytokines helps to gain control over the systemic inflammation process, hereby preventing further progress of ACLF and improve survival.

The CYTOHEP study is designed to assess the benefit of extracorporeal hemoadsorption using the CytoSorb (CytoSorbents Corporation, Monmouth Junction, NJ, USA) device in patients with ACLF. The CytoSorb device will be used in addition to continuous renal replacement therapy (CRRT) for 72 h and will be compared to a control group treated with CRRT alone. For safety assessment, a third group will be assessed without CRRT and extracorporeal hemoadsorption. All patients will be randomized in a 1:1:1 fashion in one of the study groups. Results: Our primary endpoint of the study is that extracorporeal hemoadsorption using the CytoSorb adsorber in combination with CRRT in patients with ACLF is a safe and efficient method to reduce bilirubin. In order to gain more insight into the pathogenesis of ACLF and to better understand the mode of action of the CytoSorb device a broad array of inflammatory parameters are examined.

The extracorporeal hemoadsorption with CytoSorb is clinically widely applied but lacks reliable evidence. Its application in ACLF is not justifiable since randomized controlled studies are nonexistent. The CYTOHEP study attempts to elucidate the role of extracorporeal hemoadsorption in the systemic inflammation process and progress of ACLF and represents an innovative and novel approach in the therapy of ACLF. Results: A total of 22 patients attended the 6-month PICS follow-up clinic following admission to ICU with COVID-19 pneumonitis. The majority of these patients were male and obese. The most common comorbidities were hypertension, diabetes mellitus and ischaemic heart disease. The median ICU length of stay was 21 days (IQR 2-75 days) with a median hospital length of stay of 37 days (IQR 8-130 days). The mean ICU Mobility Scale (IMS) score at the PICS clinic was low at 9.8 (SD 0.4). Only 59% of patients were independent with regard to their activities of daily living (ADLs). 8/14 (57%) of patients had returned to work by 6 months post ICU discharge. Their mean Intensive Care Psychological Assessment Tool (IPAT) score was high at 6.7 (SD 4.6) with a high mean Post-Traumatic Stress Disorder (PTSD) score of 21.1 (SD 17.5).

In this single centre prospective cohort study, we found that patients have a high burden of physical and psychological impairment at 6 months following ICU discharge post COVID-19 pneumonitis; in many cases requiring specialist referrals for long-term input. We advocate for increased resources for this much needed follow-up multidisciplinary intervention for an ever-growing population of patients. 

The aim of this study is to investigate post-intensive care syndrome (PICS) in COVID-19 patients treated in intensive care, using a validated screening tool. The COVID-19 pandemic increased pressure on critical care, but also increased the number of patients vulnerable to long-term effects of a critical care admission. PICS is a deterioration of physical, cognitive or mental functioning as a result of a critical illness, after hospital discharge [1] . PICS-Q is a validated 18-point screening tool to identify PICS. Each question has a value from 0 (never) to 3 (always) [2] . Methods: Using PICS-Q, this was a prospective single-centre study of adult COVID-19 patients treated in level 2 or 3 care for greater than 4 days, and then suitable for follow-up at the same centre. Results: From study period there were 32 eligible patients. Postal questionnaires were sent and replies were anonymised. There were 13 replies. Individual scores were combined to give a total score for each question, allowing analysis of which symptoms were most reported by patient group, seen below. Patients suffered from the physical symptoms., such as joint stiffness and fatigue and weakness the most (cumulative scores of 21, 16 and 15 from the 13 patients). Mental symptoms such as worry and ease to anger were also highly reported (16 and 13). Cognitive symptoms were reported the least apart from struggling to concentrate (Fig. 1) . Conclusions: These patients represent a snapshot of those affected by COVID-19 outbreak treated in critical care. As the number of patients treated in ICU goes up, the number of patients vulnerable to suffering from PICS will mirror that, representing a further challenge to stretched health services. Further work is required to identify and treat symptoms related to PICS. Introduction: Patients who survived from the initial attack in ICU yet represent the long-term stay status with persistent organ dysfunction are recognized as chronic critical illness (CCI) and cause heavy burden on their family, healthcare system and the society. CCI patients showed great heterogeneity. Therefore, it is important to identify the subtypes in order to guide clinical practice and trials. In this study, we used multiple machine learning methods to identified CCI phenotypes and their characteristics in disease pattern and heterogenous treatment effect. Methods: Data from three large critical care electronic healthcare record databases and one single-center tertiary referral hospital in China were extracted and formed four observational cohorts. Multiple unsupervised clustering algorithms were employed independently for phenotypes derivation and cross validation. A Bayesian-based framework was applied for treatment effect investigation. Results: In total 6862 patients were enrolled in this study. Clustering process identified four CCI phenotypes as A (mild), B (short course), C (dehydrated and catabolic multiple organ dysfunction), and D (multiple organ failure). Each phenotype showed distinct clinical features Fig. 1 (abstract P128) The validated 18-point PICS-Q questionnaire, with the cumulative scores from the patient group [2] . Participants can score each question from 0 to 3 depending on how frequently they report the symptom. This gives a total score of 39 from the patient group (as there were 13 patients). Introduction: Severity of illness scoring systems are in use in the intensive care unit setting and enable estimation for quality assurance purposes [1, 2] , but similar tools are lacking in the prehospital emergency medicine setting. Using a national helicopter emergency medical services (HEMS) database, we developed an algorithm for predicting mortality in patients treated by physicianstaffed HEMS units, suitable for real-life scenarios. Methods: We performed a retrospective observational registerbased cohort study of patients treated by all five Finnish HEMS units between 2012 and 2019. We analyzed the relationship between 30-day mortality and physiological, patient-related, and circumstantial variables and performed derivation of the multivariable models for each combination of missing variables. Data were imputed using multiple imputation by chained equations. We used Least Absolute Shrinkage and Selection Operator to select the variables for each model and pooled the results using Rubin's rule. The models were combined into an algorithm to allow risk estimation tool that accounts for missing variables. Results: 28,373 of the 36,633 patients encountered were included of whom 8,611 died before 30 days. 11 variables (systolic blood pressure, heart rate, oxygen saturation, GCS, sex, age, vehicle type, mission located in medical facility, cardiac rhythm, delay from emergency call to HEMS arrival, and dispatch code) were included. The algorithm had an area under the receiver operating characteristic (AUROC) curve of 0.932 (95% CI, 0.929 to 0.935), Brier score of 0.091, calibration intercept of − 0.002 (95% CI, − 0.041 to 0.038), and slope of 0.996 (95% CI, 0.974 to 1.018).

We present a novel severity of illness algorithm to be used in patients encountered by the HEMS that may aid in future quality improvement of HEMS and facilitate comparison between units.

Incidence and leading causes of preventable deaths in a French Introduction: Trauma remains a leading cause of death world-wide, especially among young people. Optimizing care in trauma system remains a challenge. Trauma-related preventable death (TRPD) analysis is one of the means to improve the quality of care. The aim of this study was to assess the TRPD rate in our regional trauma system. Methods: Retrospective cohort study. Trauma patients with fatal outcome hospitalized in Brest university-affiliated hospital in France between 2016 et 2020 were enrolled. Preventable death was defined using the WHO definition. All cases were reviewed by a multidisciplinary panel composed by anesthesiologist, intensivist, emergency doctor, surgeons and radiologists. Primary outcome was the TRPD incidence. Secondary outcomes were the type of errors leading to death according to the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) taxonomy. Results: 104 deaths due to trauma were reviewed. Death causes were mainly due to traumatic brain injury (70%), and hemorrhagic shock (20%). The TRPD incidence was 15.4% (7 preventable deaths, 9 potentially preventable deaths and 88 non-preventable deaths). Mean ISS in preventable deaths was 28, and 36 in non-preventable deaths (p = 0.062). 244 errors were identified, and 82 in preventable deaths (34%). Most errors (53%) were due to excessive delay (diagnostic or treatment) ( Table 1) . Conclusions: Trauma-related preventable deaths occurred in 15.4% of our patients. Triage error, delay and non-trauma-team initial resuscitation were the leading causes of errors in the studied population. Fig. 1 (abstract P129) A Consensus K-means results showed best cluster number as 4; B) UMAP plots for comparison of three independent unsupervised clustering processes (Consensus K-means, Latent profile analysis, and Self-organizing map) showed similar phenotypes distribution; C Selected representative variable property maps of SOM showed heterogeneous assignment of different subgroups; D Standardized mean values of variables barplot in four CCI phenotypes; E Chord plot showed four phenotypes with different pattern features on organ system level; F Kaplan-Meier curve showed distinct cumulative hazard in subclasses; G Bayesian hierarchical modeling revealed heterogeneity of phenotypes responses to sedation drug dose rate.

Augmented renal clearance (ARC) is increasingly recognized in critically ill patients. This condition may lead to underdosing of renally excreted medications with negative clinical outcomes. The goal of this study was to identify demographic and clinical factors associated with ARC in a mixed ICU population. Methods: This retrospective single center observational cohort study collected data of patients admitted in a mixed (medical, surgical and trauma) adult ICU. ARC, defined as a creatinine clearance of ≥ 130 ml/ min/1.73 m 2 , was assessed through weekly 24-h urine collection. Univariate analysis was used to identify variables associated with ARC which were then entered as covariates in a logistic regression using a backward stepwise selection. Goodness-of-fit of the model was assessed and a receiver operator characteristic curve was generated. Results: ARC was observed in 25.3% (n = 82) of the study cohort (n = 324). Age < 50 years old (AOR 7.32; 95% CI 4.03-13.29, p < 0.001), lower serum creatinine at ICU admission (AOR 0.97; 95% CI 0.96-0.99, p < 0.001) and admission for trauma (AOR 2.26; 95% CI 1.12-4.54, p = 0.022) were identified as independent risk factors. Our model showed acceptable discrimination in predicting ARC (area under the receiver operator curve 0.810; 95% CI 0.756-0.864, p < 0.001). Conclusions: Age < 50 years old, lower serum creatinine upon ICU admission and trauma were identified as independent risk factors for ARC. Our findings are consistent with the literature and suggest that patients with a low serum creatinine upon ICU admission could have a higher risk of developing ARC. Introduction: Serum creatinine (SCr) is used to calculate Cockcroft-Gault creatinine clearance (C&G CrCl) to estimate glomerular filtration rate (GFR) and guide drug dosing [1] . However, SCr is reported to have low sensitivity for detecting renal dysfunction in critical illness.

Population based equations such as C&G CrCl have not been validated in acute kidney injury (AKI), secondary to induced pathophysiological changes. Direct measurement of CrCl is advocated such as 4-8 h urine creatinine clearance (UrCrCl) [1] . In this retrospective analysis we describe the variation in estimated GFR (eGFR) from results of C&G CrCl, CKD-EPI eGFR and measured UrCrCl. (Table 1) .

Conclusions: UrCrCl provides a more accurate measure of GFR compared to C&G CrCl or eGFR and triggered a change in drug therapy in 52% of patients. UrCrCl is useful in patients in whom serum creatinine results may be confounded by extremes of age, frailty, low muscle mass and fluctuations in fluid balance. Thus, UrCrCl results serve to optimise drug dosing and limit risks of harm from both, toxicity and underdosing. Introduction: Augmented renal clearance (ARC) is prevalent in trauma patients and leads to subtherapeutic levels of renally eliminated medications with potentially unfavorable clinical outcomes. The Augmented Renal Clearance of Trauma in Intensive Care (ARCTIC) score has been developed to predict ARC in critically ill trauma patients. Our primary objective was to validate this score among the trauma subgroup of a mixed intensive care patient cohort.

Methods: This single-center, retrospective, observational cohort study assessed ARC using a timed 24-h urine collection performed weekly. ARC was defined as a measured creatinine clearance of ≥ 130 ml/ min/1.73m 2 . ARCTIC score performance was evaluated through an analysis of sensitivities and specificities and examination of receiver operator characteristic curves for the trauma subgroup, the medical/ surgical subgroup and the pooled cohort. Results: ARC was observed in 33.9% (n = 58) of trauma patients (n = 171) and 15.7% (n = 24) of medical/surgical patients (n = 153). Examination of different cutoffs for the ARCTIC score in our trauma population confirmed that the optimal cutoff score was ≥ 6. Comparison between ROC curves for ARCTIC score and for regression model based upon our data in trauma patients indicated validation of the score in this subgroup. Comparison of sensitivities and specificities for ARCTIC score between trauma (93.1% and 41.6%, respectively) and medical/surgical subjects (87.5% and 49.6%, respectively) showed no clinical nor statistical difference, suggesting validation for the medical/ surgical subgroup as well.

Conclusions: In our mixed ICU population, the ARCTIC score was validated in the trauma subgroup. In addition, the ARCTIC score performed well in the surgical/medical population. Future studies should assess the performance of the ARCTIC score prospectively. Introduction: The Nephrocheck ™ assay is a combination two urinary biomarkers (TIMP-2•IGFBP7) which predicts AKI risk. We investigated the association between kidney stress during early critical illness and kidney function at ICU discharge. Methods: Participants were all inpatients at a critical care unit, UK. Those who died in ICU were excluded. TIMP-2•IGFBP7 was measured on day 1, 3, 5, and 7, peak measurement in first 7 days was categorised as: Low risk (< 0.3), Low-Medium Risk (0.3-0.99), High-Medium Risk (1-2) or High Risk (2 +). eGFR at ICU discharge was assessed using creatinine and cystatin C. Differences in eGFR between groups were assessed using the Jonckheere-Terpstra test. Results: We included 35 patients, median age 54 yrs (range 21-76). Median ICU stay was 16 days (range 5-54). Median baseline eGFR-Cr was 96 ml/min/1.73 m 2 (range 16-121). 13 patients developed creatinine defined AKI in the first 10 days with 7 receiving kidney replacement therapy (KRT). Distribution of peak TIMP-2•IGFBP7 within the first 7 days was: Low risk (N 3), Low-Medium Risk (N 11), High-Medium Risk (N 11), High Risk (N 10). Cystatin C eGFR at ICU discharge was lower than creatinine eGFR (70 vs 108 ml/min/1.73m 2 , p < 0.001). No patient remained on KRT at ICU discharge. Peak TIMP-2•IGFBP7 category correlated with ICU discharge cystatin C eGFR (p = 0.0128) but not creatinine eGFR (p = 0.166) (Fig. 1) .

In critical illness assessment of kidney function is impeded by falls in creatinine generation. Here kidney stress was detected in 86% of cases whereas creatinine defined AKI was observed in 40%. When kidney function was assessed using cystatin C, severity of early kidney stress identified worse kidney function at ICU discharge. TIMP-2•IGFBP7 may help risk-stratify long term renal function following critical illness. Evaluation of kidney biomarker tests should consider using cystatin C rather than creatinine to assess kidney outcomes. 

In critically ill patients with stage 2-3 acute kidney injury (AKI) elevated urinary C-C-motif chemokine ligand 14 (CCL14) predicts persistence of severe AKI however the relationship of its trajectory to kidney outcomes has not been reported. Methods: Using existing data from two multicenter studies (Ruby and Sapphire), we analyzed urinary CCL14 at 12 h intervals after onset of moderate to severe AKI. CCL14 was measured with the NEPHRO-CLEAR ™ CCL14 Test (Astute Medical). Primary endpoint was persistent severe AKI (PS-AKI), defined as 72 h of stage 3 AKI, or death or receipt of dialysis prior to 72 h. We stratified the CCL14 concentrations into three levels: Low (≤ 1.3 ng/ml), Medium (> 1.3 to ≤ 13 ng/ml), and High (Fig. 1) .

In two-thirds of patients CCL14 levels were stable over 24 h. High CCL14 levels at any time conferred highest risk of PS-AKI while those with persistently low levels had lowest risk. Clinicians can have confidence in the prognostic interpretation of a single CCL14 result, but serial measurement may help refine prognosis over time. Introduction: The incidence and severity of postoperative acute kidney injury (AKI) can be reduced by implementing an AKI care bundle as developed by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines. However, the impact of each individual component of this bundle was unclear and was therefore investigated in this analysis. Methods: Data of the two PrevAKI-trials were combined, together including 554 cardiac surgery patients at high risk for AKI, as identified by elevated urinary biomarkers TIMP-2•IGFBP7 [1, 2] . Patients were randomized to standard of care versus implementation of the care bundle. Univariate logistic regression of the bundle's components was performed as a risk factor analysis of the whole cohort. Following this, individual treatment effects were analyzed, using the same method for the intervention group only. Results: Hypotension, low cardiac index, and use of radiocontrast agents significantly increased the risk for AKI. Similarly, optimizing the hemodynamic situation (i.e. avoiding hypotension or a low cardiac output state) was the most important individual component for the prevention of AKI. However, this was not the case for avoidance of radiocontrast. Avoidance of nephrotoxic drugs was identified as an important component in the individual treatment effect analysis, however this finding showed wide confidence intervals (Table 1) . Conclusions: Our findings demonstrate the importance of maintaining adequate systemic blood pressure and cardiac output. If hypotension or low cardiac index occurs, timely hemodynamic optimization should be performed to prevent AKI. Whilst our analyses suggested a possible role for radiocontrast agents and nephrotoxic drugs, these factors had wide confidence intervals, indicating low certainty of these findings. Besides hemodynamic optimization, other bundle components had little or no impact on the bundle's overall effectiveness. Introduction: We hypothesized that postoperative hemodynamics are strongly associated with acute kidney injury (AKI) and investigated optimal target thresholds of systemic blood pressure and cardiac output in the cardiothoracic ICU. Methods: Data of the two PrevAKI-trials were combined, together including 554 patients after cardiac surgery [1, 2] . Four hours after surgery, patients at high risk for AKI were identified by the urinary biomarkers TIMP-2•IGFBP7. Hemodynamics were then analyzed for the consecutive 12 h. In the combined dataset, the incidence and severity of AKI were compared between patients with postoperative hypotension and/or low cardiac index versus patients with hemodynamic stability. Thereafter, the incidence of AKI was evaluated for different hemodynamic thresholds of mean arterial pressure (MAP) and cardiac index (CI). Results: AKI occurred significantly more frequently in patients with postoperative hypotension and/or low cardiac index compared to patients with hemodynamic stability (57.1% vs. 37,2%, p < 0.05). This effect was especially marked for more severe stages of AKI (29.8% vs. 9,3%, p < 0.01). Our analyses demonstrated an almost constant increase in the rate of postoperative AKI with lower MAP and CI thresholds. A prominent threshold for increase in AKI rates was found at a mean MAP of between 70 mmHg or 75 mmHg and a cardiac index lower than 3.0 l/min/m 2 (Table 1) . Conclusions: Postoperative hypotension and low cardiac output are key risk factors for AKI in the ICU. For cardiac surgery patients at high risk for AKI, a higher target mean arterial pressure than the generally recommended 65 mmHg may be beneficial to prevent AKI, although this needs to be balanced against the potential side effects of required treatment intensity. Finally, our analyses strongly underline the importance of low cardiac output in the immediate postoperative period as a risk factor for kidney injury.

Introduction: Hyperreninemia after cardiac surgery may contribute to the development of acute kidney injury (AKI) [1] . Through biofeedback, angiotensin-II (AT-II) may potentially attenuate hyperreninemia, whilst maintaining target mean arterial blood pressure (MAP > 65 mmHg). This trial assesses the association between administration of AT-II and plasma renin levels in cardiac surgery patients with postoperative vasoplegia and hyperreninemia. Methods: A cohort of 40 patients after cardiopulmonary bypass (CPB) and high D-renin levels (baseline vs. 4 h after CPB, cut-off > 3.7 µU/ml, [1] ) received vasopressor therapy with either norepinephrine (NE) and AT-II or standalone NE. The primary outcome was the renin plasma level at 12 h after surgery, adjusted by baseline renin plasma level at 4 h after surgery. . AT-II effects on renin levels were particularly pronounced in patients without ACEi or ARB premedication. Finally, AT-II significantly decreased the dose of NE required to maintain the target MAP (Table 1) .

In cardiac surgery patients with post-OP vasoplegia and high D-renin levels, AT-II reduced renin plasma levels at 12 h compared to NE alone, which was associated with increased renin levels. Furthermore, AT-II significantly decreased the NE dose required to maintain target MAP. Introduction: The effects of red blood cell (RBC) transfusion on renal circulation are not elucidated yet. The aim of the study is to show the effects of RBC transfusion on renal blood flow, as detected by renal resistivity index (RRI) and renal venous stasis index (RVSI). Moreover, we hypothesized that RBC transfusion could be more significant in patients with higher oxygen extraction rate (O 2 ER). Methods: Critically ill patients who experienced Hb levels between 7 and 9 g/dl were included in the study. RBC transfusion was decided by physician; in non-transfused patients an equivalent volume of crystalloids (i.e., 250 ml) were given. The peak systolic velocity (Vmax) and the minimal diastolic velocity (Vmin) were determined from an interlobar or arcuate artery using a posterolateral approach for kidney ultrasound. The RRI was calculated as (Vmax-Vmin)/Vmax and RVSI was calculated as (cardiac cycle time/venous flow time)/cardiac cycle time. RRI and RVSI were calculated before intervention (T 1 ) and 2 h after intervention (T 2 ) from both kidney and the worst values were used for analysis. Results: Twenty-two patients were enrolled in the study. Hb was 8.6 [8-8.7] g/dl and SOFA was 8.5 [5] [6] [7] [8] [9] [10] : twelve (55%) were transfused from hospital admission to baseline and after the 1st and the last ADVOS treatments (Fig. 1) .

Overall, an improvement in acid-base parameters could be achieved in patients with acidemia treated with ADVOS, especially in blood pH, serum bicarbonate and base excess. Moreover, in patients with respiratory acidosis, a significant PCO 2 reduction could be observed. Introduction: Evidence shows COVID-19 patients requiring RRT have an increased incidence of filter cartridge failure [1] , this study aimed to reduce filter changes using an increased citrate dose protocol. Frequent filter changes can lead to reduced therapy delivery, increased cost and anaemia, however, the benefits of preserving filter lifespan must be balanced against the risks of anticoagulation associated bleeding.

Methods: A retrospective observational study was performed of our COVID-19 patients requiring RRT using an increased citrate presciption of 4 mmol/l and continuous venovenous haemodiafiltration (CVVHDF). Results: The unit treated 106 patients with COVID 19 of whom 15 required RRT. 8 patients were managed exclusively on the adjusted protocol. The median duration spent on RRT was 188 h. The average lifespan of a filter in COVID-19 patient was improved from 37 to 45 h using the increased citrate protocol. There were no adverse bleeding outcomes and no documented evidence of citrate toxicity.

Conclusions: This small study showed an improved filter life for patients on an increased citrate dose protocol of CVVHDF without any adverse outcomes. This results in cost savings and more appropriate resource usage during a pandemic without increased bleeding risk.

Another suggested measure to reduce filter malfunctions was that centres returned to using heparin anticoagulation but this is known to have increased bleeding risk [2] . Further research in a larger cohort is required but this is a promising improvement in a complex patient group. (Fig. 1) .

We have identified a clinically sound heterogeneity of treatment effect of an early vs a delayed strategy of RRT initiation that may reflect varying degrees of kidney demand-capacity mismatch.

The objective of this registry (DRKS00017068) is to collect data on real-life treatment conditions for patients for whom multiple organ support with the ADVOS albumin hemodialysis is indicated. This subgroup analysis summarizes the effect of the ADVOS therapy on acid-base parameters. Methods: The design of this patient's registry has been described previously [1] . For this analysis, all the patients enrolled until August 31, 2020, were assessed for eligibility. It comprised patients for whom a complete data set for blood gas parameters including pH, serum bicarbonate, pCO2 and base excess was documented at hospital admission, immediately before (baseline) and immediately after the first ADVOS session, and after the last ADVOS session. Patients with baseline blood pH ≥ 7.35 were classified as having "no acidemia", while patients with pH < 7.35 were subclassified into different types of acidosis. Results: 240 out of 282 patients from 5 study sites in Germany were eligible. 123 had no acidemia, while 119 were subdivided into having metabolic acidosis (34), respiratory acidosis (17), mixed acidosis (62) or compensated acidemia (6). A total of 971 ADVOS treatment sessions were documented with a median of 3 (IQR: 2, 5) sessions per patient. The median duration of the ADVOS sessions was 19 h (IQR: 12, 23). Median blood flow rate was 100 ml/min (IQR: 100,150) and median dialysate pH was 7.8 (IQR: 7.4-8.4). Significant differences were observed in the latter between patients with or without acidemia at baseline (7.4 vs. 8.0). The figure shows the course of blood gas analysis molecules to activate innate immune response via TLRs using reporter cell lines HEK-Blue hTLR9 and 7. The capacity of PMX-membrane absorption to DNA, RNA, cell-free neutrophil extracellular trap (NET) and nucleosome was estimated by incubation of these components with PMX-membrane. HEK-Blue hTLR7 and 9 cells were incubated with PMX-treated or -untreated nucleus-derived chromatin components. TLR7 and 9 activation of NF-κB were also measured. Results: One cm 2 PMX membrane can absorb 3 ± 0.01 mg authentic DNA within 5 min and removes DNA from incubation solution in a surface size-dependent manner. One cm 2 PMX membrane significantly absorb 5 ± 0.02 mg authentic RNA, 6 ± 0.02 mg nucleosome and 1. Introduction: Hemodilution after fluid bolus (FB) limits the potential increase in oxygen delivery (DO 2 ). Minimizing FB volume can decrease the hemodilution effects but also the cardiac index (CI) elevations. The study aimed to assess the DO 2 changes after FB of different technics. We speculated that FB effects on DO 2 are not inferior when a limited crystalloid fluid volume is given within a short period than larger volumes of crystalloids or colloids given at longer periods.

Methods: This prospective observational study was conducted in critically ill adult patients without active bleeding and venous-to-arterial carbon dioxide tension (PvaCO 2 > 6 mmHg) treated with FB. Arterial blood gas samples were taken, and CI was measured through transthoracic echocardiogram before and after FB. The primary endpoint was the DO 2 changes after FB, and the secondary endpoint was Hb changes. Results: Sixty patients were enrolled with P va CO 2 8.5 mmHg (IQR:7.5 to 10.2). Twenty-five patients received FB with colloids (7 ml/kg (IQR: 6.25 to 7.6)) within 30 min (IQR:28 to 39), 14 patients received FB with crystalloids (16 ml/kg (IQR: 11 to 20)) within 40 min (IQR: 28 to 40) and 21 patients crystalloids (4 ml/kg (IQR: 3.6 to 4.6)) within 20 min (infusion pump) (p < 0.01). FB with crystalloids 4 ml/kg increased DO 2 9% (IQR: − 1 to 19) compared to -2% (IQR: − 9 to 16) and 5% (IQR: − 8 to 14) in patients who received FB with higher volumes of crystalloids and colloids, respectively (p = 0.15) ( Fig. 1) . FB with crystalloids 4 ml/kg resulted to a decrease in Hb − 3% (IQR: − 6 to − 1) compared to − 7% (IQR: − 11 to − 4) and -8% (IQR: − 11 to − 5) in patients who received FB with higher volumes of crystalloids and colloids, respectively (p < 0.01). Conclusions: Fluid bolus with a limited volume of crystalloids given within 20 min has no inferior effects on oxygen delivery and has significantly lower hemodilution effects. ACs. We analysed the middle 3 ACs. Fluid removal and aspiration at PIP 20 and 30 cmH 2 O were visually assessed over 3 ACs, with trachea horizontal and 2 mL dyed saline injected between ETT cuff and lung or trachea at 45° and 2 mL saline injected above cuff, respectively.

The Figure shows effect of PIP and lung condition (C RS and R AW in cmH 2 O and l/cmH 2 O/s) on Q peak and AC time with Q ≥ 60 l/ min. Q peak ≥ 60 l/min for > 0.5 s in all scenarios. PIP and lung condition (p < 0.01) were important linear regression predictors for Q peak (multivariate model adjusted R 2 = 0.873, p < 0.001). The saline was fully removed in all scenarios, and no fluid aspiration was observed in any of the scenarios (Fig. 1) .

The TrachFlush AC produced sustained and sufficient Q peak for secretion removal and removed saline and avoided aspiration in all simulated scenarios. Introduction: Endotracheal suctioning (ETS) is performed in patients on invasive mechanical ventilation to maintain airway patency and prevent infection, but is associated with side-effects and pain [1, 2] . TrachFlush (AW Technologies) is a device automating an artificial cough (AC) method [3] . The AC is produced by rapid cuff deflation/ inflation during inspiration. At respiratory rate (RR) of 7 1/min and Peak inspiratory pressure (PIP) of 30-40 cmH 2 O the original method was shown effective [3] . This study evaluated the feasibility of using bedside selected or similar PIP and RR for AC. Methods: Patients were ≥ 18 years, orally intubated and ventilated in pressure control (PC) or pressure support (PS). In each patient, on clinical indication for ETS, 1-3 procedures each with 3 ACs were performed at PIP and RR as close to bedside settings as possible, allowing 1 s inspiratory time (VENT low ). If ETS remained indicated, three ACs were performed at increased PIP and decreased RR (VENT high ). Results: Preliminary results from 18 procedures in 8 patients.

Mean ± SD age, SAPS 3 and tube size were 79 ± 6 years; 75 ± 24 and 7.4 ± 0.5, respectively. Proportions of male patients, active humidification and PC/PS ventilation were 50%, 63%, 28%/72%, respectively. Fifteen AC procedures were successful, 5 out of 18 VENT low (28%) and 10 out of 12 VENT high (83.3%), see settings in Table. All failed procedures were in a single patient with RR 25-40 1/min. Critical-Care Pain Observation Tool (CPOT) agitation, coughing, pain and discomfort showed good tolerance to AC with improvement following AC in several procedures and deterioration following a single procedure (Table 1) . Conclusions: TrachFlush ACs successfully prevented ETS in 7/8 patients, using less excessive ventilator settings than originally proposed. Patients tolerated the ACs well. Fig. 1 (abstract P149 ) AC Qpeak and time with Q≥60 l/min vs PIP and lung condition (healthy (x), low compliance (o) and high resistance (squares)).

Feasibility study on novel usage of airway ultrasound to detect subglottic secretion above endotracheal tube (ETT) cuff-SUBSUS Methods: Forty patients meeting tracheal intubation criteria for respiratory failure were enrolled and equally randomized into 2 groups according to the used device: McGRATH Group and DL group. All patients had pre oxygenation with noninvasive ventilation with FiO 2 = 1, Pep and pressure support levels were set to achieve a tidal volume of 6 ml/kg of ideal body weight. Demographic data, difficult intubation criteria were recorded. Our primary outcome was time to intubation defined as the time from the introduction of the blade in patient's mouth until the first efficient breath delivered. Secondary outcomes were the lowest SpO 2 recorded during the procedure, the drop in SpO 2 , the number of attempts, the use of alternative methods for intubation and the experience of the operators. Results: The 2 groups were comparable concerning demographic data, BMI and difficult intubation criteria (p = 0.091). Time to intubation was shorter in the McGRATH group with no significant difference (p = 0.597). The Delta SpO 2 and the lowest SpO 2 were similar (p = 0.546 and 0.458 respectively). No difference was noticed concerning the number of attempts (p = 0.378), the use of alternative methods (p = 0.276) and the operator's skills (p = 0.076).

These results show that the DL is as effective as the recommended McGRATH video laryngoscope for intubation in COVID patients with severe hypoxemia. Introduction: In cannot-intubate, cannot-ventilate situations, a lung ventilation through a thin transtracheal cannula may be attempted [1] . However, it may be impossible to achieve sufficient ventilation if the lungs are spontaneously emptying through a thin transtracheal cannula and dangers of barotrauma may occur. Here we present a program for an automatically controlled version of a valve-a bi-directional manual respiratory pump-where a combination of low flow Introduction: COVID-19 patients are at risk of respiratory deterioration requiring higher level of care. Decisions around timing of intubation and invasive ventilation remain a challenge. NEWS2 is a well-established physiology scoring system used to detect the deteriorating patient [1] . New evidence suggests ROX index may be more reliable than NEWS2 to identify patients at risk of treatment failure of non-invasive respiratory support (NIRS) [2] . Another study has suggested the use of a nomogram for predicting NIRS failure [3] . Introduction: Inhaled nitric oxide (NO) is a pulmonary vasodilator that is inhaled and works by relaxing smooth muscle to dilate blood vessels in the lungs. It is used together with a ventilator to treat acute respiratory failure. Severe acute respiratory syndrome coronavirus, which is responsible for COVID-19 pandemic, caused a massive influx of patients presenting with acute respiratory distress syndrome (ARDS). This study aims to improved percentage of oxygenation of COVID-19 patients with acute respiratory failure using nitric oxide therapy by more than 50% by the end of 2021. Methods: The data were collected using ISBAR (Introduction-Situation-Background-Assessment-Recommendation) hand over tool and arterial blood gas results from RAPIDCOMM blood gas server from the months of May 2021 to October 2021. Data collected includes date of intubation and extubation, start date and end date of iNO treatment, blood gases measurements before, during and after iNO treatment, dose of inhaled nitric oxide in PPM (parts per million), total number of days in iNO therapy.

Introduction: Viral pneumonia is the main complication of SARS-Cov-2 infection. Many patients require prolonged invasive mechanical ventilation and subsequent tracheostomy [1] . There is no standard recommendation about the optimal timing for the procedure [2, 3] . The aim of this study was to describe the clinical outcomes in COVID-19 patients who underwent early versus late tracheostomy. Methods: A retrospective single-center observational descriptive study was performed at a fourth level hospital on patients with confirmed diagnosis of COVID-19 and admission to the ICU who required mechanical ventilation and subsequent tracheostomy between January and July of 2021. Group analysis by the timing of tracheostomy [4, 5] . ICLOS and LOS seem to be shorter in early tracheostomy group. Other outcomes such as morbidity, time to decannulation and the possibility of early pulmonary rehabilitation should be included in future studies.

Introduction: Recruitment maneuvers (RM) are designed to open collapse lungs and keep them opened, based on the application of high pressures during a period of time. However, they expose the patient to hemodynamic instability and their beneficial effects are debatable. Lateral positioning does not require the application of higher airway pressures and could promote alveolar recruitment due to changes in regional transpulmonary pressure. Methods: Six pigs were submitted to invasive mechanical ventilation under general anesthesia. A lung injury model was produced by sequentially applying lung lavage followed by injurious ventilation to obtain a PF ratio < 100 mmHg. After injury, a RM was performed and open-lung-PEEP (lowest PEEP with collapse < 1%) was chosen during a decremental PEEP titration guided by EIT. After observing massive collapse at PEE p = 5 cmH 2 O, animals were ventilated with VT = 6 ml/ kg, RR 25 bpm and optimal PEEP without recruitment maneuver. All animals were sequentially positioned at (1) supine position, (2) tilted to the left (down), (3) back to supine, (4) tilted to right (down) during 20 min, and finally back to (5) supine. We evaluated the end expiratory lung impedance (EELZ), arterial blood gases, and respiratory mechanics. Paired T tests were performed to compare the first supine with the last supine position. Results: all animals presented an increase in respiratory compliance (p = 0.008; Fig. 1A ) and PaO 2 /FiO 2 ratio (p = 0.009; Fig. 1C ). In five of six animals EELZ increased (p = 0.07), while one animal lost aeration probably due to insufficient PEEP (Fig. 1B) . The amount of mass of collapsed lung measured by EIT decreased after the lateral positioning (p = 0.02; Fig. 1D ). Adverse hemodynamics effects were not observed. Conclusions: Sequential lateral positioning effectively works as a recruitment maneuver, opening collapsed lung areas, improving respiratory mechanics, oxygenation and EELZ, without requiring high airway pressures and presenting no adverse hemodynamics effects. 

The respiratory mechanics of CARDS at the time closest to the initiation of invasive mechanical ventilation was normally distributed and did not reveal any distinct C RS -based phenotypes.

However, to what extent the proposed unique pathophysiology of CARDS affects the current definition of ARDS and "exposes" its potential limitations remains a question for a high-quality, large prospective dataset to answer. Nonetheless, from our study-level analysis, C RS appears to be a heterogenous metric affected by both disease and intervention factors (Fig. 1) and physicians should treat patients with personalised and precise interventions in this context. Introduction: Acute exposure to hypercapnia has shown benefit to diaphragm function in porcine and rat ICU models of mechanical ventilation (MV), within 72 h. Here, we hypothesize that normoxic and non-acidotic hypercapnic conditions (NAHCs) would limit the loss of diaphragm function during MV for longer duration. Methods: Adult Sprague-Dawley rats were deeply sedated, pharmacologically paralyzed, hydrated, nourished and controlled mechanical ventilated (CMV) for 5 days in normoxic-normocapnic or normoxic and NAHCs (EtCO2: 55-70 mmHg with normal blood pH). Diaphragm fibers from euthanized rats were prepared for contractile function assessment and downstream signaling pathways analyses. Results: Our results show that: (1) cross sectional area (CSA) was decreased by 40% following normocapnic CMV when compared with control sham operated (CTR) (p < 0.001), which was unaltered by NAHCs; (2) Specific force (SF: force normalized to CSA) was decreased to 58% of CTR following normocapnic CMV (p < 0.001). NAHCs increased SF by 15% compared with normocapnic rats (p < 0.05); (3) Muscle E3 ligases Murf1 and Atrogin-1 protein expression is unchanged following 5 days of CMV, irrespective of C02 conditions. LC3B, a marker for autophagy, with LC3B II:I ratio signifying activation. Following 5 days normocapnic CMV LC3B II:I ratio (p < 0.05) was reduced by 70% in diaphragm. NAHCs failed to alter the activation of LC3B or these muscle degradation pathways; (4) NAHCs however increased TNFα and IL-1β transcript expression in the diaphragm compared with normocapnic CMV and CTR groups; (5) As expected, NAHCs increased stability of respiratory peak pressure, peripheral oxygenation and perfusion, hemodynamic conditions. Conclusions: Our results suggest that NAHCs have beneficial effects on single diaphragm fibers function irrespective of significant increase in muscle inflammation in non-septic animals. This, combined with the positive respiratory and hemodynamic effects, encourage further study of the therapeutic potential of CO 2 in ICU. 14) for LI-TTDN50% + MV, and 6 (4-9) for LI-TTDN100% + MV. Homovanillic acid serum concentrations (ng/ml) were: 8 (7-13) for LI-MV, 6 (3-7) for LI-TTDN50% + MV, and 3 (3-4) for LI-TTDN100% + MV. Spearman correlation test showed a positive, linear, and moderate correlation between TUNEL-positive cell percentage and homovanillic acid serum concentration, r = 0.75, p = 0.0003 (Fig. 1) .

We found a moderate correlation between the TUNELpositive cell percentages and dopamine production in our moderate-ARDS preclinical model, and that TTDN subjects showed lower cellular apoptosis and dopamine production compared to MV only with LI. Hippocampus was harvested at study end, and ionizing binding adaptor molecule-1 (IBA-1) and glial fibrillary acid protein (GFAP) assays were used to stain microglia and astrocyte cells respectively. Positive-stained hippocampal cell percentages were determined using machine-learning software (ImageJ). Spearman test was run to investigate association between IBA-1 and GFAP hippocampal percentages. P-values < 0.05 are considered statistically significant. Results: IBA-1-and GFAP-positive cell percentages found were [median (interquartile range)]: 18 (17-32) and 18 (14-24) for LI-MV, 12 (11-13) and 12 (9-15) for LI-TTDN50% + MV, 8 (7-10) and 9 (8-10) for LI-TTDN100% + MV, and 10 (8-10) and 10 (9-11) for NV. Spearman correlation test showed positive, linear, and moderate correlation between hippocampal IBA-1 and GFAP percentages, r = 0.57, p = 0.0031 (Fig. 1) .

We found a moderate correlation between the percentages of hippocampal microglia and astrocytes after 12 h of MV with moderate ARDS, and that TTDN mitigated neuroinflammation in our injured-lung model. 

The electrical activity of the diaphragm (Edi), the main inspiratory muscle, reflects the neural control of respiration. There is limited knowledge of the correlation between Edi, the pressure generated during inspiration (ΔPes) and the ultrasonographic extent of its thickening (TFdi). The main aim of the current study was to assess the correlation between Edi, ΔPes and TFdi. Methods: Patients > 18 years were enrolled if they were undergoing weaning in NAVA and with a catheter for ΔPes measurement. A stepwise NAVA level reduction was performed (-25%, -50%, -75% from baseline). During each step, an arterial sample was taken for gas analysis, neuroventilatory coupling parameters were recorded and respiratory muscle ultrasound was performed. Comparison of data was performed with one-or two-way ANOVA and linear mixed models were built to assess the relationship between variables. Two-tailed, p < 0.05 was considered statistically significant. Results: We enrolled 16 patients (10 males, age 64 ± 17 years, BMI 24 ± 5 kg/m 2 ), after an average of 8 ± 3 days from ICU admission. At enrolment, the PaO 2 /FIO 2 ratio was 300 ± 91 mmHg, patients were ventilated with PEEP 7.7 ± 2.2 cmH 2 O and FIO 2 0.35 ± 0.1. Baseline NAVA level was 1.1 ± 0.7 cmH2O/uV, and Edi was 12.3 ± 8.5 uV. We found a significant correlation between Edi and ΔPes (R 2 = 0.32, p < 0.001), while no significant correlation was found between Edi and TFdi (R 2 = 0.01, p = 0.105). After analysis of individual patient data, we found two different behaviours of the Edi-TFdi relationship: a group in which the two variables were linearly correlated (preserved coupling), and one in which such coupling was not preserved (Fig. 1) . A higher rapid shallow breathing index, a higher Edi, a lower respiratory system compliance, and a lower neuroventilatory and neuromechanical efficiency were found in patients with non-preserved coupling. Conclusions: Edi is not always associated with TFdi; several physiological parameters were associated with the presence of a preserved or non-preserved coupling. [1] . The aim of this work is the study of the association between the diaphragmatic excursion(DE) measured with US and the weaning from MV. Methods: 105 patients have been enrolled and they started pressure support ventilation(PSV) weaning trial. In all, DE was evaluated by viewing the right hemi-diaphragm using a 10 MHz linear probe in the right intercostal area. The US examination was performed at the same time as blood gas sampling and the measurement of ventilatory parameters. After 12 h of PSV, the patients started spontaneously breathe. If they were able to maintain spontaneous ventilation for the next 12 h, they were assigned to the successful weaning group (SW) otherwise to the failed weaning group (FW). The product between DE and respiratory rate, the DER, was calculated for each patient. Using the Mann-Whitney U test, the DER parameter was compared between SW and FW groups and in the subgroups of overweight/obese patients (p = 0.05).

Results: 57 patients are in SW group and 48 patients in FW group. There are not statistically differences in age, sex and weight class. The mean DER in SW group was 28.5 ± 27.7 cm; in FW group was 15.2 ± 8.6 cm; this difference is statistically significant (p = 0.028). Comparing the subpopulations of overweight and obese patients, the mean DER is 32.47 ± 3.2 cm in the SW, while in the FW is 13.9 ± 7.4 cm, with a statistically significant difference (p = 0.012). Conclusions: Patients who were successfully weaned from MV had higher DER values during the weaning trial. These results allow us to hypothesize the use of DER as a predictive index of weaning from MV. [2] . Current practice aims to reduce VILI in ARDS patients by limiting driving pressure. We previously showed that temporary transvenous diaphragm neurostimulation (TTDN) reduces driving pressure in normal lungs ventilated for 50 h; here we investigate whether TTDN reduces driving pressure in a moderate-ARDS preclinical model [3] . Methods: Moderate ARDS was induced in deeply sedated pigs, mechanically ventilated using volume-control mode at 8 ml/kg, PEEP 5 cmH 2 O, with respiratory rate and FiO 2 set to achieve normal arterial blood gas values. ARDS was induced using oleic acid, delivered via the pulmonary artery until PaO 2 /FiO 2 < 200. Animals were then ventilated for 12 h post-injury. MV + TTDN100% group (n = 6) received TTDN synchronized to inspiration on every breath, targeting a reduction in ventilator pressure-time-product of 15-20%; MV group (n = 6) received volume-control ventilation only. Results: Transpulmonary driving pressure was lower both at postinjury and at study-end, and total study exposure to transpulmonary driving pressure was 36% lower in the MV + TTDN100% group than the MV group. TTDN on every breath limited transpulmonary driving pressure below 10 cmH 2 O post-injury and at study-end. Median transpulmonary driving pressure was 6.2 cmH 2 O greater in MV than MV + TTDN100% at study-end (Fig. 1) . Conclusions: TTDN reduces transpulmonary driving pressure by 36%, reducing the risk of VILI and the relative risk of death in a moderate-ARDS model. Introduction: PaO 2 /FiO 2 is the main clinical tool used to categorize the level of acute lung injury in ventilated patients and has been shown to be well correlated with atelectasis in the context of the utilization of lung recruitment strategies [1] . It is also used to categorize the degree of severity of lung injury. We have previously shown that temporary transvenous diaphragm neurostimulation (TTDN) mitigates PaO 2 /FiO 2 loss in pigs with healthy lungs ventilated for 50 h [2] . This study investigated the impact of TTDN on PaO 2 /FiO 2 in a moderate-ARDS preclinical model, with mechanical ventilation (MV) for 12 h post-oleic-acid-induced lung injury. Methods: MV was delivered to deeply sedated pigs using volumecontrol mode at 8 ml/kg, PEEP 5 cmH 2 O, with respiratory rate and FiO 2 set to achieve normal arterial blood gas values. Moderate ARDS was induced using oleic acid, delivered via the pulmonary artery until PaO 2 /FiO 2 < 200. Animals were then ventilated with the same strategy for 12 h post-injury. MV + TTDN100%-group (n = 6) received TTDN synchronized to inspiration on every breath, targeting a neurostimulation-induced reduction in ventilator pressuretime-product of 15-20%; MV-group (n = 6) received volume-control MV only. Results: PaO 2 /FiO 2 was not statistically different at baseline or post-injury and was higher at study-end in MV + TTDN100% (432 (383-490)) than MV (364 (327-376), p = 0.0360). PaO 2 /FiO 2 recovery over time was better in MV + TTDN100%, and was affected by time (p < 0.0001), and interaction of TTDN and time (p = 0.0275) (Fig. 1) . Conclusions: PaO 2 /FiO 2 recovery was faster with TTDN in a moderate-ARDS model, compared to lung-protective MV alone. We previously published that TTDN, using the same neurostimulation approach as this study, mitigated PaO 2 /FiO 2 loss in healthy-lung pigs ventilated for 50 h. These findings indicate that TTDN results in better PaO 2 /FiO 2 both in homogenous and heterogenous lungs. (5) .

Neither R/I ratio nor recruitable volume differentiates recruiters from nonrecruiters by staircase recruitment maneuver P Aramareerak, P Watcharasint Phramongkutklao Hospital, Pulmonary and Critical Care Medicine, Bangkok, Thailand Critical Care 2022, 26(Suppl 1): P176

Introduction: A single-breath method allows bedside measurement of recruitment-to-inflation (R/I) ratio and recruited volume (Vrec). To date, there is a limit number of studies regards to these parameters compare between recruiters vs. nonrecruiters identified by staircase recruitment maneuver (SRM). Using SRM, we hypothesize whether recruiters would have a higher R/I ratio and higher Vrec than nonrecruiters. Methods: We conducted a prospective experimental study in patient with acute respiratory distress syndrome (ARDS) who were admitted to a medical intensive care unit. All patients were measured for R/I ratio and Vrec. After that, SRM was performed to identify patients as recruiters (improvement of respiratory compliance (Crs) ≥ 30%) and nonrecruiters (improvement of Crs < 30%). Arterial blood gas parameters and respiratory mechanics were recorded at the baseline, end of SRM, 1 h, and 4 h following SRM. Primary outcome was difference in R/I ratio between recruiters vs. nonrecruiters. Secondary outcome was difference in Vrec between both groups. Results: Twenty-two ARDS patients were enrolled. The most common cause of ARDS was pneumonia (n = 16). Median PaO 2 /FiO 2 ratio at the baseline was 176 (interquartile range 93-230). Using improvement of Crs criteria following SRM, there were 17 nonrecruiters and 5 recruiters. No difference in R/I ratio was found between recruiters and nonrecruiters (0.33 vs. 0.23, p = 1.0) ( Fig. 1 upper panel) . Compared to nonrecruiters, there was a trend of higher Vrec in recruiters but not achieved statistically significant (330 ml vs. 380 ml, p = 0.31). While there was no different in baseline plateau and driving pressure, Recruiters had significantly lower delta plateau and driving pressure following SRM ( Fig. 1 lower panel) . Conclusions: In patients with ARDS, using R/I ratio may not help differentiate recruiters and nonrecruiters identified by Crs improvement. However, there was a trend of higher Vrec in recruiters. These findings warrant further study. Introduction: Purpose of the study: to analyze the effectiveness of the use of intravenous ECMO as part of the complex therapy of patients with confirmed SARS-Cov-2 infection. Methods: VV-ECMO was used in 19 patients (11 men, 8 women) over 18 years old (50 ± 12.5) with body mass index 32 ± 3.4 and severity of organ dysfunctions SOFA 3 points. Previously, all patients underwent therapy with interleukin-6 receptor inhibitors and glucocorticoids, non-invasive ventilation. The duration of mechanical ventilation before the start of ECMO was 1 ± 0.75 days, PaO 2 /FiO 2 index-68 ± 12 mmHg, pHa were 7.25 ± 0.06, lactate 2.5 ± 0.6 mmol/l. ECMO was connected according to the femoral vena-jugular vein scheme, volumetric flow rate 3-4 l/min, oxygen 3 l/min. Results: Disconnected from ECMO 37% (7), discharged 26% (5), 60day survival-26%. Patients with an unfavorable outcome, compared with those who were discharged, had pronounced leukocytosis 14(10-17) versus 8 (4-8) × 10 9 /l, p = 0.009) and lymphocytopenia 7 ± 4% versus 12 ± 2%, p = 0.007). After initiation of the procedure, by day 3 in the lethal group: SOFA scores increased from 3 to 9 (in the group of survivors from 3 to 4 (p = 0.027)); the level of procalcitonin from 0.2 to 1.45 ng/ml; the number of platelets decreased by 48% (in the group of survivors it increased by 42% (p = 0.011); PaO 2 /FiO 2 index did not change significantly (an increase of 200% in the group of survivors up to 206 mmHg (p = 0.011). The following complications developed in the group of patients with an adverse outcome: bleeding from cannulation sites (26.3%, n = 5), nosebleeds (26.3%, n = 5), circuit thrombosis (10.5%, n = 2) and pneumothorax (5.2%, n = 1). Conclusions: VV-ECMO is an effective method of supporting lung function in patients with confirmed SARS-Cov-2 infection. The presence and progression of a bacterial infection is a predictor of an adverse outcome. Introduction: In patients with severe respiratory failure from COVID-19, extracorporeal membrane oxygenation (ECMO) can facilitate lung-protective ventilation and may improve outcome. The aim of this study is to investigate the clinical course, characteristics and outcomes of patients supported with ECMO for COVID-19 pneumonia. Methods: All adult patients with a confirmed diagnosis of COVID-19 pneumonia admitted to the ICU of Jessa Hospital, Belgium and treated with ECMO between March 13, 2020, and June 30, 2021, were included. Data were prospectively entered into a database that included medical history, demographic data, laboratory results, ventilator settings, ventilator-derived parameters, therapeutic interventions and clinical outcomes. This database was retrospectively reviewed. The primary endpoint is ICU mortality. The study population is categorized based on primary endpoint. A Student t test or Mann Whitney U test and a Chi Square or Fisher's Exact tests were used to evaluated differences between survivors and non-survivors. A p < 0.05 is considered statistically significant. Results: A total of 295 COVID-19 patients were admitted to the ICU, 24 needed ECMO and were analysed. Medical history, demographic data, laboratory results, ventilator settings, ventilator-derived parameters, therapeutic interventions and clinical outcomes, stratified for ICU mortality were analysed. ICU mortality was 45.8% (11/24). Only the following variables were significantly associated with ICU mortality: lower hospital length of stay (p = 0.01), need of continuous veno-venous hemofiltration (CVVH) during ECMO (p = 0.01), higher incidence of stroke (p = 0.04) and major bleeding (p = 0.004) ( Table 1) . Conclusions: We were not able to identify baseline variables, treatment and/or ventilator strategies nor laboratory results that are associated with ICU mortality in this small cohort of COVID-19 patients supported with ECMO. Our results suggest that CVVH, stroke or major bleeding during EMCO treatment may increase the risk of ICU mortality. Introduction: In mechanically ventilated patients suffering from ARDS as a consequence of COVID-19 interstitial pneumonia, we have often noted pneumomediastinum development despite the use of protective mechanical ventilation [1] . The purpose of this study is to determine whether the incidence of pneumomediastinum in patients with COVID-19 ARDS was higher than in ARDS patients without COVID-19 and whether this difference could be attributed to barotrauma or pulmonary fragility. Methods: We divided the patients into two groups: Group A (patients with ARDS from COVID-19), Group B (patients with ARDS from other causes). All patients were admitted to ICU (intensive care unit) and treated with protective mechanical ventilation-tidal volume 4-6 ml/ kg of IBW (ideal body weight), plateau pressure ≤ 28 cmH 2 O, driving pressure ≤ 12-14 cmH 2 O. Results: In group A, pneumomediastinum occurred in 8 of 59 patients(13.5%) while in group B in 1 of 59 (1.6%) (p < 0.001). Mortality was 58% in group A patients while 48% in group B patients (p = 0.32). In group A the mean of tidal volume used was 5.6 ± 0.7 ml/kg of IBW, the mean of plateau pressure 22 ± 5 cmH 2 O and driving pressure 11 ± 4 cmH2O. In group B the mean of tidal volume used was 5.9 ± 0.5 ml/kg of IBW, the mean of plateau pressure 23 ± 4 cmH 2 O and driving pressure 10 ± 3 cmH 2 O. Conclusions: The incidence of pneumomediastinum was approximately 8 times higher in the group of patients with COVID-19 ARDS despite the use of protective ventilation. This complication could be the consequence of greater lung fragility in patients with COVID-19 ARDS rather than in barotrauma which refers to elevated transpulmonary pressure. Introduction: Invasive ventilation initiation after a prolonged period of non-invasive ventilation (NIV) trial can be associated with poor outcome in coronavirus disease 2019 (COVID-19) ARDS patients. This study aimed to document our center's experience with COVID-19 ARDS patients treated with veno-venous ECMO (VV-ECMO) after a prolonged NIV trial period to avoid intubation. We speculated that VV-ECMO support is not associated with a worse outcome than invasive ventilation in these patients.

We retrospectively reviewed 6 patients with COVID-19 ARDS who presented severe hypoxemia and pneumomediastinum after NIV (ECMO group). Twenty patients with COVID − 19 and age less than 70 years old were treated in the first wave of the national outbreak and underwent NIV trials for more than 24 h before intubation (Control group). The primary outcome was intensive care unit (ICU) survival and secondary ECMO or mechanical ventilation weaning at 28 days.

The age of the patients in the ECMO group was 59 years (IQR: 46 − 65) and SAPS II score 47 (IQR: 46 − 52), compared to 60 years (IQR: 51 − 66) (p = 0.71) and 48 (IQR: 45 − 54) (p = 0.63) in the control group. NIV duration before ECMO or invasive ventilation initiation was 5 days (IQR: 2 − 8) and 3 days (IQR: 1 − 5), respectively (p = 0.13). Drainage multistage femoral cannula 25 F and internal jugular infusion cannula 21 F were placed percutaneously. After cannulation, the patients received light sedation that permitted communication, active physiotherapy and oral feeding. None of the patients in the ECMO group died within 28 days after ECMO initiation ( Fig. 1, Panel A) or received invasive ventilation. VV-ECMO was not associated with longer mechanical support than invasive ventilation (HR: 1.26 95%CI: 0.24 − 6.55, p = 0.77) (Fig. 1, Panel B) . Conclusions: VV-ECMO can be a not inferior strategy to invasive ventilation for treating patients with COVID-19 ARDS and severe hypoxemia not responding to long trials of NIV. Introduction: Extracorporeal membrane oxygenation (ECMO) provides a rescue strategy in treatment of acute respiratory distress syndrome (ARDS). However, its use can be associated with serious complications and hepatic dysfunction is a commonly observed phenomenon. Due to several limitations of studies addressing liver dysfunction results are conflicting and to date there is no conclusive evidence of impact of altered liver dysfunction in prognostication of VV-ECMO support survival. This is further limited by a lack of data regarding sequential alterations of liver parameters during ECMO support [1] . We aimed for detection in trends of liver dysfunction as a prognostic value to predict survival of VV-ECMO support in a large cohort. Methods: Retrospective, monocentric evaluation of VV-ECMO patients from the years 2013-2021. Liver dysfunction was assessed by sequential measurements of bilirubin and liver enzymes (ASAT, ALAT). Patients were evaluated in regard to mortality, disease severity (SOFA-Score on ICU admission, duration of ECMO support, ICU/hospital length of stay). The study has been approved by the local ethics committee (#492/20). All values are mean ± standard deviation(SD) or median ± interquartile range (IQR). Univariate time dependent Cox proportional hazard (CoxPH) analyses were performed using R. Results: 366 (262 male) patients underwent VV-ECMO for ARDS. Grouped (by in-hospital survival status, survivors vs. non-survivors) stats: age 51 ± 12 vs. 56 ± 12 years (p < 0.001), weight 102 ± 33 vs. 94 ± 32 kgs (p = 0.02), height 175 ± 10 vs. 174 ± 9 cm. Median ECMO-support was 13 ± 9 vs. 16.7 ± 27 days (no differences between groups), SOFA Score on ICU admission was 8 ± 2. vs 9 ± 3 (p = 0.005). Hazard ratios for liver parameters are depicted in the Figure (Fig. 1) . Conclusions: Time dependent CoxPH analysis revealed bilirubin and ASAT as independently increase the risk of death on VV ECMO support. 

Excess O 2 administration and hyperoxemia were common in mechanically ventilated patients with SARS-CoV-2 and may be associated with ICU-mortality and greater risk for VAP.

The use of mechanical power and driving pressure during mechanical ventilation for ARDS in an ICU in a lower income country (Sri Lanka) K Indraratna, H Yapa, D Jayasekera Sri Jayewardenepura General Hospital, Anaesthesia and Intensive Care, Nugegoda, Sri Lanka Critical Care 2022, 26(Suppl 1): P185

To determine the use of mechanical power [1] and driving pressure [2] during ventilation for ARDS in a lower income country.

To assess whether these measurements affect outcomes in patients with ARDS being treated in a lower middle income country. Methods: Patients who fulfilled the Berlin criteria for ARDS [3] were recruited. The arterial blood gas immediately prior to ventilation, the 1st post ventilation blood gas, the ventilator settings on which the patient was stabilized on the first day were considered. The 1st post ventilation blood gas should have fulfilled the Berlin criteria as well to remain in the study. Patients with ejection fractions less than 30, and GCS of 3 prior to ventilation were excluded. Mechanical power and driving pressure were calculated from the first day's finalized ventilator settings. The ventilator settings, blood gas reports and chest X-rays were collected by an observer who was not privy to the measurements being made. The staff in the ICU were not aware of the measurements being taken.

There were 20 patients. Mortality was 60%. 45% had mechanical power of over 12. Mortality 88.9%. 55% had mechanical power less than 12. Mortality 45%. 50% had driving pressure of over 14. Mortality 100%. 50% had driving pressure of less than 14. Mortality 20%. 33% had driving pressure over 14 and mechanical power over 12. Mortality 83%. 20% had driving pressure less than 14 and mechanical power less than 12. Mortality 0%. Documentation of values of mechanical power and driving pressure-0%. Conclusions: The mortality for ARDS was high. Due attention has not been paid to these parameters. Mortality was high when the values were high. Driving pressure correlates better with mortality rates than mechanical power. When both mechanical power and driving pressure were normal mortality was 0. Introduction: Despite many advances made with weaning protocols, the need for reintubation still arises in 10%-20% of patients extubated after successful weaning [1] . Such extubation failure (EF) is associated with prolonged mechanical ventilation and mortality [2] . Dead-spaceto-tidal-volume ratio (Vd/Vt) as an indicator of extubation outcome was investigated in several studies, however, the results were inconsistent. We hypothesize that higher Vd/Vt values are associated with EF. Thus, we aimed to assess the utility of Vd/Vt in predicting EF among mechanically ventilated ICU patients via a systematic review and meta-analysis of observational studies.

A systematic search (PubMed, Scopus and ScienceDirect; in March 2021) was performed for published papers that investigated the relationship between Vd/Vt and outcome of extubation following successful spontaneous breathing trial. Pooled Vd/Vt mean difference (MD) between extubation outcomes, and pooled Vd/Vt predictive accuracy measures (sensitivity [Sn], specificity [Sp], diagnostic odds ratio [dOR] and summary area under the curve [AUC]) were determined using a random-effects model. Subgroup analysis based on age (pediatric vs adult) was likewise done. Results: Eight studies (684 patients) met the inclusion criteria. Optimal Vd/Vt cutoffs ranged from 0.50 to 0.65. EF patients had higher mean Vd/Vt relative to extubation successes (MD = 0.12; 95% CI 0.06-0.18; p < 0.01). Pooled Sn, Sp and dOR were 0.79 (95% CI 0.66-0.88), 0.74 (95% CI 0.67-0.81) and 9.72 (95% CI 3.89-24.32), respectively. The summary AUC (Fig. 1) is 0.83 (95% CI 0.79-0.86). No significant differences in pooled estimates between the age subgroups were noted. Conclusions: Vd/Vt is a potential predictor for EF given its modest Sn and Sp, high dOR and moderate-to-high summary AUC. However, further studies are needed to determine a single optimal Vd/Vt cutoff, above which EF is expected. Introduction: Beneficial effects of prone position on outcome in ARDS may be related to decreased anterior chest wall compliance, which facilitates lung recruitment. The effects of anterior external chest wall compression (AEC) in supine position on respiratory mechanics and gas exchange are less well known [1] . We aimed to evaluate the effects of AEC in invasively ventilated COVID-19 patients. Methods: In 10 sedated and paralyzed COVID-19 patients ventilated in volume control mode, airway and esophageal pressures, driving pressure (DP) and lung compliance (Clung) were recorded before (baseline) and during (5 kg, 10 kg) AEC (10-min epochs). AEC was performed [1] . World pandemic was declared by the WHO in March 2020 [2] . Since then, millions of patients have been infected worldwide. Our group published in March 2021 a multicentre study analysing the prevalence and risk factors for delirium in critically ill patients with COVID-19 infection [3] . In this sub analysis of the main study, the primary outcome was the association of sedation level since ICU admission with 28-day mortality in patients admitted to ICU due to COVID-19. Methods: The exposure tested against mortality was excessive sedation (in the coma range) defined as 'Did patients have a documented sedation score in the coma range at any point this day? RASS = − 4 or − 5; SAS = 2 or 1; MAAS = 0 or 1; Ramsay 5 or 6″. Data from 2017 patients was available for analysis, collected after patients' admission to ICU. Other covariates analyzed were baseline patient characteristics, medical history and treatment applied in the ICU. Logistic regression was used in all analyses and results presented as odd ratios (OR) with 95% confidence intervals. Results: Deep sedation (RASS = − 4 or − 5, SAS = 2 or 1, MAAS = 0 or 1, Ramsay 5 or 6) was positively and significantly associated to mortality within 28 days since ICU admission. P value was 0.012 and the OR was 2.00 with a 95% confidence interval of 1.16-3.45. Conclusions: As shown by this sub analysis, deep sedation increases mortality rates in critically ill COVID 19 patients. We should try to decrease sedation levels to avoid RASS of − 4 and − 5 to favor patients' outcomes admitted to the ICU. Critical Care (2022) 26:72

was similar between groups (3.5 vs. 4), while the number of oral agents (opioids, BZD, phenobarbital) was higher in the COVID group (0 vs. 2). Conclusions: There were a similar number of IV agents used between the two cohorts. Oral medications were used more often to augment sedation in the COVID cohort of this study.

Effect of ramelteon on reducing in-hospital mortality in critically ill adults: a nationwide observational cohort study in Japan T Takeuchi Introduction: Delirium is a common complication in intensive care units (ICU) and is considered to be an independent risk factor for mortality [1] . Some studies have attempted to show preventative effects of pharmacological treatments including ramelteon, melatonin receptor agonists, but none have been proven to improve major outcomes [2] . Recent small studies reported that ramelteon may prevent critically ill patients from developing delirium [3] , but the data are limited and the effect of ramelteon on mortality is still unknown. Our aim is to determine whether ramelteon reduces mortality in critically ill adults. Methods: We conducted a cohort study using the Diagnosis Procedure Combination database in Japan. We enrolled adult patients admitted to the ICU from April 2018 to March 2021 in Japan. We excluded patients who were admitted to the ICU after 48 h of hospital admission and were discharged or died within 2 days of ICU admission. After multiple imputation (MI) for missing values, propensity score (PS)-based fine stratification weighting (FSW) analysis was performed to compare in-hospital mortality between patients who were administered ramelteon within 48 h of admission (ramelteon group) and those who did not (control group). Results: Of 39,869 ICU patients, 1,755 were in the ramelteon group and 38,144 were in the control group. After MI, PS-based FSW improved the balance of background factors between the two groups. Administration of ramelteon was associated with decreased days of haloperidol use (-0.101 days; 95% CI, − 0.190 to − 0.012) and reducing in-hospital mortality (10.2% vs 12.0%; odds ratio 0.832; 95% CI, 0.695 to 0.996). Conclusions: For critically ill adults, treatment with ramelteon within 48 h of admission was associated with reducing days of haloperidol use and in-hospital mortality. Introduction: Objective is to study the effect of different concentrations of sevoflurane on the activation of human neutrophils in an ex vivo model.

The study was carried out on a cell culture of venous blood neutrophils of 5 healthy men. LPS and chemotaxis peptide fMLP as stimulants, was assessed by the expression level of CD11b and CD66b, IL-1b, IL-6 and IL-8, the level of phosphorylation of glycogen synthase GSK-3β. Annexin V and propidium iodide were used to assess apoptosis. Results: Incubation of neutrophils with LPS and fMLP statistically significantly increased the expression of these molecules, namely, when LPS was treated at a dose of 200 ng/ml, the expression of CD11b and CD66b increased 2.3 and 2.2 times (p = 0.002 and p = 0.001, respectively), and upon treatment with fMLP at a dose of 100 nm., the expression of CD11b and CD66b increased by 1.7 and 2.0 times (p = 0.025 and p = 0.03, respectively). Upon incubation of neutrophils with the same LPS concentration after exposure to sevoflurane at a dose of 1.5 MAC, the expression level of CD11b and CD66b increased compared to intact neutrophils. The change in CD11b expression in this experiment was statistically insignificant (p = 0.055), the change in CD66b expression was statistically significant (p = 0.007). Thus, exposure to sevoflurane at a dose of 1.5 MAC decreases the pro-inflammatory activation of neutrophils by LPS. Stimulation of neutrophils by LPS was accompanied by dephosphorylation of GSK-3β, and exposure to 1.5 MAC of sevoflurane resulted in its phosphorylation. Thus, phosphorylation of GSK-3β in neutrophils by sevoflurane reduces the expression of CD11b and CD66b. Conclusions: Sevoflurane has a pronounced anti-inflammatory effect due to the suppression of neutrophil hyperactivation; one of the possible mechanisms of the effect of sevoflurane on the function of neutrophils is the phosphorylation of GSK-3β. I  II  III  IV IL-8, pg/ml 9,641 ± 2,038 9,357 ± 1,541 15,659 ± 4,113 10,968 ± 2,019 IL-6, pg/ml 3,114 ± 0,842 2,877 ± 0,692 6,550 ± 0,784 30,890 ± 4,557 IL-10, pg/ml 4,118 ± 0,751 4,618 ± 0,890 16,158 ± 4,126 5,142 ± 0,732 TNF, pg/ml 8,391 ± 0,450 7,915 ± 0,387 8,316 ± 0,435 7,005 ± 0,347 Introduction: Immune cell dysfunction is a crucial part in sepsis. Granulocyte concentrate (GC) transfusions, as the only available immune cell concentrates, potentially induce tissue damage via local effects of neutrophils. Therefore, using the donor immune cells purely extracorporeally is an attractive option. Clinical trials with standard GC in an extracorporeal plasma treatment achieved beneficial effects. In this ex vivo study, purified GC with longer storability were investigated in a simplified extracorporeal plasma treatment system. Methods: Purified GC (pGC) were stored up to 3 days and used in a plasma perfusion therapy model simulating a 6 h treatment. The extracorporeal circuit consists of a blood circuit and a plasma circuit with 3 plasma filters (PF) (Fig. 1) . PF1 is separating the plasma from the patient's blood, plasma is perfused through PF2 containing the donor immune cells and only the treated plasma is re-transfused. A PF3 is included in the plasma backflow as a redundant safety measure. 1000 ml donor plasma was used to simulate patients. Granulocyte efficacy 

References 1

References 1

References 1

References 1. Crash-2 Collaborators

References 1

References 1

Veno-venous extracorporeal membrane oxygenation (ECMO) in non-intubated patients with COVID-19 acute respiratory distress syndrome (ARDS): a non-inferiority study

References 1

Better response was related to an anteriorly located baby lung on CT imaging. At baseline, median transpulmonary DP (Pl DP) was 17.46 (IQR 11.50-25.07) cmH 2 O and decreased with 16.2 ± 4.9% and 20.6 ± 8.2% during 5 kg and 10 kg AEC, respectively (Fig. 1b, p < 0.001). pCO 2 decreased in 4 patients and remained equal in 2 patients (Fig. 1c). The latter group also had minimal change in Pl DP and Clung. In all patients PO 2 decreased with need for increasing FiO 2 . Median P/F ratio of 124 (IQR 104-143) mmHg at baseline decreased to 105

P191 Dexmedetomidine increases central venous oxygen saturation in patients undergoing neurosurgery MC Niño 1 , D Cohen 1

Per BSA (m2)# 1156

Comparing only patients that were further sedated after the study period (43 Iso patients vs 81 iP patients); the Iso group had more ICU-FD (14.7 vs. 9.6, p = 0.017) than the iP group

Controlling for SAPS II at baseline; the Iso group had more ICU-FD than the iP group (15.6 vs 12.4 ICU-free days, p = 0.043). VFD for Iso vs iP were 18

Controlling for SOFA score 48 h after randomisation; ICU-FD were more with Iso than with iP: 17.9 vs 13.3, p = 0.005. VFD for Iso vs iP were 20

Results: Cells were viable throughout the study period and exhibited well-preserved functionality and efficient metabolic activity. No indication of immune cell impairment was detected. Also, cytokines are actively secreted during the extracorporeal treatment simulation. Of particular interest is equivalence in performance of the granulocytes on day 1 and day 3, demonstrating sustained shelf life of pGC. Conclusions: Results demonstrate that cells are highly active in removing toxic or inflammatory compounds from plasma and secreting cytokines into plasma. Furthermore, granulocytes remain viable and active even after storage

Acknowledgement: Study's Other Collaborators: DPG, DB, JME, CEG, CR, DL, YL, FD, AD, GD. Acknowledgement: The data collection was registered with MEC-U as nWMO W20.090. Acknowledgments: Thanks to Jeong Y, Kang J, for allowing use of PICS-Q here. Conclusions: This preliminary data demonstrates improved compliance of the aeriated lung by decreasing hyperinflation. No evidence for recruitment was found in contrast to existing literature showing improved oxygenation [2]. onto mucosa. These observed biochemical properties could explain the beneficial effects of IgM/IgA-enriched immunoglobulins compared to standard IVIg in therapy of severe infections.

during inspiration, by reducing gas supply to the valve, and increased flow during expiration, by increasing gas supply to the valve, permits more effective Venturi effect and efficient expiration, with low total gas consumption. Methods: The theoretical performance of the valve was modeled mathematically. The effectiveness of the valve that was predicted by the mathematical model was tested in vitro with a standard valve but by variable flow rates. Conclusions: Satisfactory lung ventilation can be assured with transtracheal ventilation with a bidirectional manual respiration valve with variable gas flow. Results: Based on the patients data collected from May to October 2021, 91-95% of COVID-19 patients who were treated with iNO in the months of May, June, July showed improvement in oxygenation and were wean-off from ventilator ( Fig. 1) . During the month of August 2021, influx of ARDS due to COVID-19 became twice as much the number compared from the previous months and it was observed during the months of August and September 2021. Number of patients without improvement in oxygenation has increased due to several factors such as availability of nitric oxide (NO) machine and co-morbidities like chronic renal failure. Conclusions: Our data indicates that the utilization of iNO is useful in improving arterial oxygenation of COVID-19 patients and could provide immediate help and delay of respiratory deterioration and further complications. Introduction: The aim of this study was to describe the use of high flow nasal oxygen (HFNO) in COVID-19 intensive care unit (ICU) patients [1] locally, and establish their demographics and outcomes. Mater Dei Hospital is the only main acute general hospital on the island. It houses a 20-bedded adult ICU catering for a population of 500,000.

We conducted a single-centre prospective observational cohort study at the ICU at Mater Dei Hospital in Malta between March 2020 and May 2021. Data collected included use of HFNO, mechanical ventilation (MV), duration of MV, length of stay, and 28-day survival. Results: 240 COVID-19 ICU patients were included. 108 (45%) received HFNO for a median of 3 days, the rest received MV for a median of 12 days. No major differences in demographics were noted (age: 66.5 vs 68 years, p = 0.225; 70% male, 30% female vs 79% male, 21% female, p = 0.191). Forty-two (38.2%) patients failed HFNO after a median of 2 days, needing MV for a median of 10 days (p < 0.001). Median length of stay was lower in HFNO patients (6 vs 13 days; p < 0.001). 28-day survival was highest in the HFNO-only group (94%), followed by the HFNO + MV group (61%), and finally the MV-only group (52%; p < 0.0001). This is not simply due to severity since FiO 2 was higher for HFNO patients and PaO 2 tended to be lower. Cox proportional hazards analysis showed that respiratory support was more significant than admission P/F ratios, PaO 2 s, or SOFA, with MV being linked to a hazards ratio of 8.4 (p < 0.001) when adjusted for the above criteria. Conclusions: HFNO offers considerable practical advantages over MV. Avoiding MV might be linked to a reduced incidence of ventilator-associated pneumonias, shorter ICU stay and lower mortality. It is also a safe tool to use and the risk of aerosolization should not deter from its use. 

In this retrospective analysis, ECMO therapy with Cyto-Sorb was associated with higher in-hospital mortality and an increased rate of bleeding events compared to ECMO runs without CytoSorb. Introduction: The multicenter CTC Registry study collected patientlevel data in COVID-19 patients receiving CytoSorb therapy under FDA Emergency Use Authorization. An earlier report on the first 52 CTC patients on ECMO treated with CytoSorb showed 69% overall survival [1] . The current analysis focuses on changes in pulmonary function relative to the time of CytoSorb therapy. Methods: A total of 56 patients from 5 U.S. centers were included. Data on demographics, mechanical ventilation (MV), ECMO, and arterial blood gases during CytoSorb therapy were analyzed. Linear regression was used to evaluate the relationship between the timing of initiation of CytoSorb therapy to lung oxygenation according to changes in PaO 2 /FiO 2 ratio. Results: In the current analysis, 71% (40/56) overall survival was observed. For these survivors, time to CytoSorb start after ICU admission, MV start, and ECMO start was 138 ± 171.3 h, 83 ± 111.0 h, and 55 ± 156.5 h, respectively, with mean duration of CytoSorb therapy of 83 ± 29.1 h. At the first 24 h following CytoSorb therapy, oxygenation was improved evidenced by decreased MV FiO 2 and ECMO FdO 2 requirements and an increased PaO 2 /FiO 2 ratio (90.2 ± 58.13 mmHg to 166.3 ± 98.67 mmHg, p < 0.001, N = 21). Linear regression analysis suggested that earlier initiation of CytoSorb therapy following ICU admission may be correlated to greater improvements in PaO 2 /FiO 2 ratio (r = -0.37, p = 0.103), however, this trend did not achieve statistical significance. Conclusions: High survival rates have been observed with adjunct CytoSorb therapy in critically ill COVID-19 patients on ECMO. The current analysis suggests that early initiation of hemoadsorption following ICU admission may contribute to earlier improvements in native lung oxygenation. Introduction: Even if life-saving in most cases, excess O 2 may have adverse effects. We described the prevalence of hyperoxemia and excess O 2 administration in patients with severe acute respiratory syndrome due to novel coronavirus (SARS-CoV-2) and explored the association with mortality in the intensive care unit (ICU) or ventilatorassociated pneumonia (VAP Introduction: Current literature regarding sedative dosing in venovenous extracorporeal membrane oxygenation (VV-ECMO) is sparse, with information pertaining to those with SARS-CoV-2 (COVID) requiring VV-ECMO being even rarer. The purpose of this quality improvement project was to examine the sedation practices and requirements of patients who received VV-ECMO in the year prior to and the first year of the COVID epidemic. Methods: This was a single-center, observational study. Adults who received VV-ECMO from January 1, 2019 through December 31, 2020 were included. Those who received VV-ECMO in 2019 were considered the pre-COVID cohort, while those who received VV-ECMO during 2020 were the COVID cohort. Demographics, clinical and lab parameters, and doses of oral and intravenous (IV) opioids, benzodiazepines (BZD), and other sedatives were recorded. Results: Twelve pre-COVID and 13 COVID patients were included with a mean duration of VV-ECMO of 10 and 27 days, respectively. Mean medication doses during the first week of VV-ECMO and mean duration of use are described in Table 1 . Patients who received IV opioids (11 vs. 13), IV BZD (12 vs. 13), and propofol (10 each) were similar between groups. Median number of IV sedation agents used Fig. 1 (abstract P187) a Clung during baseline, 5 kg AEC and 10 kg AEC (n = 10), b Pl DP (n = 10), c PCO 2 (n = 6). Gray: individual patients. Blue line: median values + IQR.

Introduction: Dexmedetomidine decreases sympathetic tone and reduces cerebral metabolic rate [1, 2] , important benefits in neurosurgery. We aimed to evaluate the effect of this medication on systemic metabolic markers that reflect the oxygen supply and demand relationship. Our hypothesis was that dexmedetomidine will diminish oxygen consumption in patients under general anesthesia and we would see an increase in central venous oxygen saturation (ScvO 2 ). Methods: A quasi-experimental design, including patients at least18 years old programmed for craniotomy between April 2019 and March 2020 was conducted. We excluded patients with hemodynamic instability, ventilator support, hemodynamic support, anemia, oxygen requirement, sepsis, systemic inflammatory response, and pregnancy. A sample size of 66 was calculated. After induction, a central venous catheter was placed, a sample of blood was obtained (T0), and dexmedetomidine infusion (0.3 μg/kg/h) was started. A second sample was obtained 60 min later (T1) before incision was made. ScvO 2 and lactate were measured in both samples. Global and stratified statistical analysis for paired samples were carried out. Results: A sample of 75 was analyzed. Overall, dexmedetomidine increased ScvO 2 (81.2% in T0 to 82.9% in T1; p 0.05). When stratified analysis was conducted, the increase in ScvO 2 was significant in patients older than 65 years (p = 0.02) and patients with tumor (vs vascular lesion, p = 0.03). Lactate levels were constant across time. Conclusions: Dexmedetomidine increases ScvO 2 under general anesthesia without modifying lactate levels, especially among patients older than 65 years. Even though the difference was small, further studies are needed to elucidate clinical benefits of dexmedetomidine in neurosurgery. 

Intravenous lidocaine has demonstrated to attenuate the proinflammatory effects associated with surgery, in addition to its analgesic properties [1] . Effective modulation of the inflammatory response may improve outcomes for patients undergoing craniotomy. We hypothesized that intravenous lidocaine would attenuate the inflammatory response to craniotomy, measured using widely available biomarkers (neutrophil to lymphocyte ratio [NLR] and platelet to lymphocyte ratio [PLR]). Methods: A retrospective cohort study was conducted included patients at least 18 years old undergoing craniotomy under general anesthesia form January 2015 to December 2019. Exclusion criteria were simultaneous procedures, fever, sepsis, and intraoperative vasopressors. Anesthesia technique was standardized. Lidocaine use was at the discretion of the anesthesiologist. NLR and PLR were measured before and 24 h after surgery. The primary outcome was a reduction in biomarkers in the patients exposed to lidocaine. Secondary outcomes were ICU stay, postoperative septic shock, and mortality 20 days after surgery. Results: A sample of 165 patients was analyzed, and 84 (50.9%) of them were exposed to lidocaine. Preoperative and 24-h postoperative values of NLR and PLR were similar between groups of patients. There were no differences in ICU length of stay, opioid consumption, incidence of septic shock, and mortality. Patients who received intraoperative lidocaine had less opioid consumption than those who were not exposed (p < 0.01). Conclusions: Intravenous lidocaine during craniotomy did not blunt the inflammatory response associated with this procedure. However, less opioid consumption was associated with intraoperative infusion of this local anesthetic. 

We aimed to study the dose equivalency of fentanyl and morphine when used for analgosedation in adult mechanically ventilated ICU patients. Methods: This is a post hoc analysis of a previously published prospective cluster-crossover trial of fentanyl vs. morphine infusion for analgosedation in two university-affiliated hospital ICUs in Melbourne, Australia [1] . Patient height and weight were collected as part of routine nursing observations. Body mass index (BMI), body surface area (BSA), ideal body weight (IBW) and lean body weight (LBW) were calculated using these observations by validated formulae. In one center, hourly data on narcotic dose were extracted from electronic information. In the other center, narcotic dose data were manually extracted from observation charts at 4-h intervals and missing data was linearly imputed. Results: In the initial trial, the median (IQR) ages were 59 (44-68; n = 344; male = 63%) in the fentanyl group and 59 (45-72; n = 337; male = 62%) in the morphine group. The median (IQR) weights (kg) were 84 (70-100; n = 317) in the fentanyl group and 82 (70-95; n = 309) in the morphine group. There were 261 patients in the fentanyl group and 273 patients in the morphine group in which the height and weight were both recorded. Of these, the median (IQR) BMI (kg/m 2 ) was 30 (25-34) and 29 (25-33), the median (IQR) BSA (m 2 ) was 2.0 (1.8-2.2) and 2.0 (1.8-2.1), the median IBW (kg) was 63 and 65, and the median LBW (kg) was 57 and 58 for fentanyl and morphine respectively. Table 1 provides the doses and ratios of fentanyl to morphine. The ratios of fentanyl to morphine ranged from 1:48 to 1:59. Conclusions: The dose equivalency of IV fentanyl to IV morphine has traditionally been described as 1:100. We have shown when used for analgosedation, the dose equivalency of fentanyl to morphine is approximately 1:55 and doesn't vary significantly when adjusting for weight, BMI, BSA, IBW and LBW. 

All data presented as median (IQR); *: hourly dose calculated by total amount divided by number of hours drug administered; $: n = 317 (fentanyl) and 309 (morphine); # n = 261 (fentanyl) and 273 (morphine) (Table 1) . For IL-8 and IL-10, the highest average value is achieved at the stage of hemostasis, while the value of IL-8 is on average one and a half times higher, and the value of IL-10 is four times higher.Conclusions: When analyzing the concentrations of pro-inflammatory and anti-inflammatory interleukins, depending on the stage of the perioperative period, the balance of their changes is shown. Pharmacological effect on the opioid and alpha-2-adrenergic systems of the brain provides modulation of the response to stress. 

The Sedaconda study was an RCT in invasively ventilated patients, comparing inhaled isoflurane (Iso) via the Sedaconda Anaesthetic Conserving Device (ACD) to iv propofol (iP) [1] . 150 patients received Iso and 151 iP, for up to 48 ± 6 h or extubation, whichever was first. Continued sedation, if needed, was at the physician's discretion. We compared ICU-free days (ICU-FD) and ventilator-free days (VFD) in patients receiving the initial drug and never converting to the other drug in the 30 days from randomisation. Methods: 69 Iso patients not switching to iP and 109 iP patients not switching to Iso after the study period were analysed. Study groups had similar demographic and clinical baseline characteristics (Table 1) .

The Iso group had significantly more ICU-FD than the iP group (15.9 vs 11.6, p = 0.008). VFD in Iso and iP were 18.6 and 16.6 respectively (p = 0.231). Additional analyses:Conclusions: Isoflurane, via Sedaconda ACD, as the primary sedative was associated with more ICU-free days than intravenous propofol. Ventilator-free days favoured isoflurane but differences did not reach statistical significance. Introduction: Severe infections are still a major health burden. Beneficial effects of treatment with IgM/IgA-enriched immunoglobulins compared to standard IVIg were reported and attributed to the additional IgM and IgA component [1] . Nevertheless, the molecular structure of such complex preparations is not fully understood. Especially in focus of respiratory diseases are multimeric IgM and IgA species that could be transported to mucosa [2] . The aim of our work was to characterize an IgM/IgA-enriched immunoglobulin with focus on IgA, IgM and the presence of J-chain which enables immunoglobulin transport to mucosa. Methods: We characterized the IgM/IgA-enriched immunoglobulin Pentaglobin ® (76% IgG, 12% IgA, 12% IgM) by measuring the ratio of IgG and IgA subclasses. Relative distribution of monomeric and multimeric immunoglobulins was analyzed by size exclusion chromatography. Specific detection of IgG, IgA, IgM and J-chain was performed by western-blot. J-chain was quantified by ELISA.

The immunoglobulin distribution reveal the presence of several immunoglobulin isotypes (IgG/IgA/IgM) as well as IgG and IgA subclasses. Molecular size distribution reveal multiple multimeric species. Subsequent western-blot analysis shows pentameric IgM and dimeric IgA with J-chain, as well as monomeric IgG and IgA (Fig. 1) . J-chain ELISA quantifies a notable portion of IgA and IgM molecules that is associated with J-chain. Introduction: The role of intravenous immunoglobulin (IVIG) as an adjunctive treatment for severe sepsis remains controversial [1] . We hypothesized that IVIG associated with antibiotics could be more effective than antibiotics alone for treating patients with severe pneumococcal pneumonia.

We performed a retrospective study and analyzed the data of 2 groups of 20 patients presenting severe pneumoccocal pneumonia and admitted in an university ICU between 2015 and 2019. All The patients were 60 + -10 years old and mechanically ventilated. On admission, a first group receiving IVIG and antibiotics (study group) and a second group receving placebo(saline) and antibiotics (control group). IVIG were administered on the first hour of admission at a dose of 0.5 g/kg during 3 days and infused continuously at 3 ml/kg/h. IVIG were preceded by administration of ceftriaxon-levofloxacin. We recorded in the 2 groups: CRP, SOFA score Day 1 and Day 4, Time on mechanical ventilation(MV), PaO 2 /FiO 2 ratio on day 1 and day 3, the incidence of septic shock, ICU stay, the hospital length of stay (LOS) and 28-day mortality.Results: Statistical analysis used Mann-Whitney test and results expressed as mean with standard deviation (Table 1) . We observed that SOFA score Day 3, time on MV, ICU stay and LOS were significantly reduced in study group compared to control group. PaO 2 /FiO 2 Day 3 was more elevated in study group than in control group, respectively 220 + -5 vs 180 + -6 p < 0.001. Septic shock was present in 10 patients sur 20 in control group and in 6 patients sur 20 in study group. Day 28 mortality was significantly decreased in study group compared to control group respectively 30% vs 50%. Conclusions: Early administration of high doses IVIG combined with antibiotics improved outcome of patients with severe pneumoccocal pneumonia. A randomized controlled study, including a large population of patients is needed to confirm these interesting results. Introduction: High circulating levels of histones were correlated to sepsis severity and worse outcome. Our hypothesis was that the neutralization of histones with sodium-β-O-methyl cellobioside sulphate (STC3141, from Grandpharma, China) in sepsis might improve sepsis outcome. Methods: Sepsis was induced by fecal peritonitis in twenty-four mechanically ventilated, hemodynamically monitored female sheep. Animals were randomized to three groups control, concurrent treatment (CuT) and post treatment (PT) group (N = 8 each) after surgical preparation and stabilization. STC3141 was given as bolus (1 mg/ kg) + continuous (1 ml/kg/h). It was started at sepsis inducement in the CuT group and 4 h after in the PT group. During the first 4 h, fluid was maintained at 2 ml/kg/h. 4 h after sepsis, fluid resuscitation (maintain pulse pressure variation < 13%), antibiotics and peritoneal lavage were administrated, and norepinephrine was given to maintain mean arterial blood pressure > 65 mmHg if necessary. Experiment lasted for 24 h. Results: During the first 4 h, MAP was maintained in the CuT group, while dropped significantly in the PT and Control group. Significantly lower dose of NE and lactate levels was observed in the two treatment groups compared to the control group. Impaired sublingual microcirculation significantly improved at 6 h in the two treatment groups at 18 h in the PT group. Survival benefit tended to be longer in the two treatment groups (p = 0.075). Conclusions: Neutralization of histones with STC3141 in sepsis quickly stabilized hemodynamics with less NE utilization, ameliorated impaired microcirculation and improved tissue perfusion, which might provide a new therapeutic approach for sepsis. 

After viral or bacterial sepsis, most intensive care unit (ICU) patients enter a state of profound immunosuppression contributing to patients' worsening. Transgene has developed an immunotherapy based on a viral vector encoding human interleukin-7 (hIL-7) to restore both innate and adaptive immune responses. Here, we assessed the capacity of hIL-7 to improve ex vivo T lymphocyte function from septic shock and COVID-19 patients. Methods: Primary human hepatocytes were transduced with MVA-hIL-7-Fc, a recombinant Modified Vaccinia virus Ankara (MVA) encoding the hIL-7 fused to the human IgG2 Fc fragment, or with empty MVA as control. Cell culture supernatants were harvested for further assays. T cells were collected from ICU patients (septic shock = 11, COVID-19 = 29) and healthy donors (n = 21). STAT5 phosphorylation, cytokine production (ELISpot and intracellular staining) and cell proliferation were assessed upon TCR stimulation with supernatants containing or not hIL-7 produced after MVA transduction or with the counterpart recombinant hIL-7 (rhIL-7).

Patients with viral and bacterial sepsis display T lymphocyte alterations compared to healthy donors with a decreased production of cytokines and a decreased proliferation capacity. Supernatant containing hIL-7 induces STAT5 phosphorylation in CD3 lymphocytes of all patients. With 90% of responders, hIL-7 boosts cytokines production (single and double IFN-TNF) and T lymphocytes proliferation capacity at the same level as rhIL-7 in both cohorts whereas empty MVA has no effect.Conclusions: This study indicates that hIL-7-Fc produced after MVA transduction initiates IL-7 signaling through the phosphorylation of STAT5 and restores ex vivo human lymphocyte functions in cells from septic patients with acquired immunosuppression. This proof-of-concept study, along with experimental results in animal models, supports the clinical development of the MVA-hIL-7-Fc in sepsis immunosuppressed patients.

Extracorporeal immune cell therapy of sepsis-ex vivo one-way results G Klinkmann 1 , T Wild 2 , B Heskamp 2 , F Doss 2 , S Doss 2 , M Milej 2 , DA Reuter 1 , S Mitzner 3 , J Altrichter 2 1 University Medical Center Rostock, Department of Anaesthesiology Introduction: Immune cell dysfunction is a crucial part in sepsis and in particular in septic shock. Granulocyte concentrate (GC) transfusions, as the only available immune cell concentrates, potentially induce tissue damage via local effects of neutrophils. Therefore, using donor immune cells purely extracorporeally is an attractive option. Clinical trials with standard GC in an extracorporeal plasma treatment achieved beneficial effects. In this clinical trial, purified GC with longer storability will be investigated in a streamlined extracorporeal plasma treatment.

We describe a prospective, phase II, multicenter, randomized controlled parallel-group clinical trial in patients with refractory septic shock. Subjects suffering from septic shock according to Sepsis-3-Definition who additionally require norepinephrine at a dose of ≥ 0.2 mcg/kg/min (and/or vasopressin at any dose) for a minimum of 6 h (within the last 48 h will be randomized. Patients are randomized to receive either standard of care therapy or extracorporeal immune cell therapy on top of standard of care, in a 1:1 ratio. A total of 120 evaluable patients will be enrolled at 4 sites within Germany. Primary endpoint is safety and tolerability consisting of overall mortality and new onset of serious adverse events. A key secondary endpoint is showing recovery from immune dysfunction after extracorporeal immune cell treatment. Results: This study has been submitted to independent ethics committees and responsible agencies in Q4/2021 and is expected to start in Q1/2022 (Fig. 1) . Conclusions: The extracorporeal immune cell plasma perfusion therapy may on one hand provide immune support and may avoid unwanted local side effects on the other hand. Recovery from immune dysfunction is a prerequisite for avoiding secondary infections and ultimately also for recovery from sepsis.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Fig. 1 Scheme of the extracorporeal immune cell plasma perfusion therapy. Plasma is continuously filtered from the patient's extracorporeal blood circuit and transferred into a closed-loop 'cell circuit' , where the patient's plasma is brought into direct contact with therapeutically effective, human-donor immune cells (i.e. granulocyte concentrate).